Document:

EX-10.12

 Exhibit 10.12 

 

			
	From:	  	Trajectory Alpha Acquisition Corp.
		  	99 Wall Street, #5801
		  	New York, New York 10005
		
	To:	  	The Purchaser[s] Identified on the Signature Page Hereto
		
	RE:	  	Securities Purchase Agreement
		
	Date:	  	____________, 2021

 Ladies and Gentlemen: 
 This
agreement (this “Agreement”) is entered into on the date set forth above by and between the purchaser[s] signator[y][ies] hereto (the “Purchaser”) and Trajectory Alpha Acquisition Corp., a Delaware corporation (the
“Company”). This Agreement may be executed by an investment manager on behalf of managed funds and/or accounts set forth on Exhibit A hereto and for the elimination of doubt each such fund or account shall, severally and not jointly, be
the Purchaser hereunder. Pursuant to the terms hereof, the Company hereby accepts the offer the Purchaser has made to subscribe for and purchase the number of shares (the “Shares”) of Class B common stock, $0.0001 par value per share,
of the Company (the “Class B Common Stock”) specified on the signature page to this Agreement, all of which are subject to forfeiture by the Purchaser pursuant to Section 3 if the Purchaser’s indication of interest in the
initial public offering (the “IPO”) of units (the “Units”) of the Company, which shall not in the aggregate, when taken together with the Units purchased by any Attribution Party (as defined herein) of the Purchaser, be greater
than the lesser of (i) Units with an aggregate public offering price of $[ ] and (ii) [ ]% of the Units sold in the IPO (for the avoidance of doubt, without regard for any Units sold as part of the exercise of the over-allotment option) (the
“IPO Purchase Amount”), is withdrawn or not fulfilled. The Company’s and the Purchaser’s agreements regarding such Shares are as follows: 

1. Purchase of Shares. 
 1.1. Purchase of Shares. For the sum set
forth on the signature page hereto (the “Purchase Price”), the Company hereby agrees to sell the Shares to the Purchaser, and the Purchaser hereby agrees to purchase the Shares from the Company on the terms and subject to the conditions
set forth in this Agreement. The closing of the purchase of the Shares shall take place immediately prior to the closing of the IPO, and the Purchaser shall deliver the Purchase Price for the Shares no later than two (2) business days prior to
the closing of the IPO in accordance with written instructions provided by the Company. Upon payment of the Purchase Price for the Shares in accordance with this Agreement, the Company shall promptly effect delivery of the Shares in book-entry form.

 1.2 Limitations on Voluntary Conversion. Notwithstanding anything to the contrary in this Agreement or the Company’s certificate of incorporation,
the Company shall not effect the voluntary conversion of any Shares into shares of Class A common stock, $0.0001 par value per share, of the Company (the “Class A Common Stock”), and the Purchaser shall not have the right to
convert any such Shares pursuant to the terms and conditions of this Agreement or the Company’s certificate of incorporation and any such conversion shall be null and void and treated 

 
as if never made, to the extent that, after giving effect to such conversion, the Purchaser together with other Attribution Parties collectively would beneficially own in excess of 9.90% (the
“Maximum Percentage”) of the shares of Class A Common Stock outstanding immediately after giving effect to such conversion. For purposes of the foregoing sentence, the aggregate number of shares of Class A Common Stock
beneficially owned by the Purchaser and the other Attribution Parties shall include the number of shares of Class A Common Stock held by the Purchaser and all other Attribution Parties plus the number of shares of Class A Common Stock
issuable upon conversion of the Shares with respect to which the determination of such sentence is being made, but shall exclude shares of Class A Common Stock which would be issuable upon (A) conversion of the remaining, non-converted Shares beneficially owned by the Purchaser or any of the other Attribution Parties and (B) exercise or conversion of the unexercised or non-converted
portion of any other securities of the Company (including, without limitation, any warrants) beneficially owned by the Purchaser or any other Attribution Party subject to a limitation on conversion or exercise analogous to the limitation contained
in this Section 1.2. For purposes of this Section 1.2, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of
determining the number of outstanding shares of Class A Common Stock that the Purchaser may acquire upon the conversion of the Shares without exceeding the Maximum Percentage, the Purchaser may rely on the number of outstanding shares of
Class A Common Stock as reflected in (x) the Company’s most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Securities and Exchange Commission (the “SEC”), as the case may be, (y) a more recent public announcement by the Company or (z) any other written notice by the
Company or the transfer agent of the Company, if any, setting forth the number of shares of Class A Common Stock issued and outstanding (the “Reported Outstanding Share Number”). If the Company receives a request for conversion of the
Shares from the Purchaser (a “Conversion Request”) at a time when the actual number of issued and outstanding shares of Class A Common Stock is less than the Reported Outstanding Share Number, the Company shall notify the Purchaser in
writing of the number of shares of Class A Common Stock then outstanding and, to the extent that such Conversion Request would otherwise cause the Purchaser’s beneficial ownership, as determined pursuant to this Section 1.2, to exceed
the Maximum Percentage, the Purchaser must notify the Company of a reduced number of shares of Class A Common Stock to be delivered pursuant to such Conversion Request. For any reason at any time, upon the written or oral request of the
Purchaser, the Company shall within one (1) business day confirm orally and in writing or by electronic mail to the Purchaser the number of shares of Class A Common Stock then outstanding. In any case, the number of outstanding shares of
Class A Common Stock shall be determined after giving effect to the conversion or exercise of securities of the Company by the Purchaser and any other Attribution Party since the date as of which the Reported Outstanding Share Number was
reported. In the event that the issuance of shares of Class A Common Stock to the Purchaser upon conversion of the Shares results in the Purchaser and the other Attribution Parties being deemed to beneficially own, in the aggregate, more than
the Maximum Percentage of the number of outstanding shares of Class A Common Stock (as determined under Section 13(d) of the Exchange Act), the number of shares so issued by which the Purchaser’s and the other Attribution
Parties’ aggregate beneficial ownership exceeds the Maximum Percentage (the “Excess Shares”) shall be deemed null and void and shall be cancelled ab initio, and the Purchaser shall not have the power to vote or to transfer the Excess
Shares. Upon delivery of a written notice to the Company, the Purchaser may from time to time increase (with such increase not effective 

 
until the sixty-first (61st) day after delivery of such notice) or decrease the Maximum Percentage of the Purchaser to any other percentage not in excess of 9.90% as specified in such notice;
provided, however, that any such increase in the Maximum Percentage will not be effective until the sixty-first (61st) day after such notice is delivered to the Company. For clarity, the shares of Class A Common Stock issuable to the Purchaser
upon conversion of the Shares pursuant to the terms of the Company’s certificate of incorporation in excess of the Maximum Percentage shall not be deemed to be beneficially owned by the Purchaser for any purpose including for purposes of
Section 13(d) or Rule 16a-1(a)(1) of the Exchange Act. For the purposes of this Agreement, “Attribution Parties” shall mean, collectively, the following persons and entities: (i) any
investment vehicle, including, any funds, feeder funds or managed accounts, currently, or from time to time after the issue date of the Shares, directly or indirectly managed or advised by the Purchaser’s investment manager or any of its
affiliates or principals; (ii) any direct or indirect affiliates of the Purchaser or any of the foregoing; (iii) any Person acting or who could be deemed to be acting as a “group” (as such term is used Section 13(d) of the
Exchange Act and as defined in Rule 13d-5 thereunder) together with the Purchaser or any of the foregoing; and (iv) any other persons whose beneficial ownership of the Class A Common Stock would or
could be aggregated with the Purchaser’s and the other Attribution Parties for purposes of Section 13(d) of the Exchange Act. For clarity, the purpose of the foregoing is to subject collectively the Purchaser and all other Attribution
Parties to the Maximum Percentage. For the avoidance of doubt, notwithstanding the foregoing, the Shares shall not be convertible into or exchangeable for, either at the election of the Purchaser or otherwise, shares of Class A Common Stock at
any time prior to the completion of the Company’s initial business combination. 
 2. Representations, Warranties and Agreements. 

2.1. Purchaser’s Representations, Warranties and Agreements. To induce the Company to sell the Shares to the Purchaser, the Purchaser hereby represents
and warrants to the Company and agrees with the Company as follows: 
 2.1.1. No Government Recommendation or Approval. The Purchaser understands that no
federal or state agency has passed upon or made any recommendation or endorsement of the offering of the Shares. 
 2.1.2. No Conflicts. The execution,
delivery and performance of this Agreement and the consummation by the Purchaser of the transactions contemplated hereby do not violate, conflict with or constitute a default under (i) the formation and governing documents of the Purchaser,
(ii) any agreement, indenture or instrument to which the Purchaser is a party or (iii) any law, statute, rule or regulation to which the Purchaser is subject, or any agreement, order, judgment or decree to which the Purchaser is subject,
except in the case of clauses (ii) and (iii), that would not reasonably be expected to prevent the Purchaser from fulfilling its obligations under this Agreement. 

2.1.3. Organization and Authority. The Purchaser is validly existing and in good standing under the laws of its jurisdiction of formation and possesses all
requisite power and authority necessary to carry out the transactions contemplated by this Agreement. Upon execution and delivery by the Purchaser and the other parties hereto, this Agreement is a legal, valid and binding agreement of the Purchaser,
enforceable against the Purchaser in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting the enforcement of creditors’ rights generally
and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity). 

 2.1.4. Experience, Financial Capability and Suitability, No Reg D Disqualification. The Purchaser is
(i) sophisticated in financial matters and is able to evaluate the risks and benefits of the investment in the Shares and (ii) able to bear the economic risk of its investment in the Shares for an indefinite period of time because the
Shares have not been registered under the Securities Act (as defined below) and therefore cannot be sold unless subsequently registered under the Securities Act or an exemption from such registration is available. The Purchaser is capable of
evaluating the merits and risks of its investment in the Company and has the capacity to protect its own interests. The Purchaser must bear the economic risk of this investment until the Shares are sold pursuant to (i) an effective registration
statement under the Securities Act or (ii) an exemption from registration available with respect to such sale. The Purchaser is able to bear the economic risks of an investment in the Shares and to afford a complete loss of the Purchaser’s
investment in the Shares. The Purchaser is not subject to any “bad actor” disqualification under Rule 506(d) of Regulation D under the Securities Act of 1933, as amended (the “Securities Act”). 

2.1.5. Access to Information; Independent Investigation. Prior to the execution of this Agreement, the Purchaser has had the opportunity to ask questions of
and receive answers from representatives of the Company concerning an investment in the Company, as well as the finances, operations, business and prospects of the Company, and the opportunity to obtain additional information to verify the accuracy
of all information so obtained. In determining whether to make this investment, the Purchaser has relied solely on the Purchaser’s own knowledge and understanding of the Company and its business based upon the Purchaser’s own due diligence
investigation and the information furnished pursuant to this paragraph or as described in this paragraph. The Purchaser understands that no person has been authorized to give any information or to make any representations which were not furnished
pursuant to or as described in this Section 2 and the Purchaser has not relied on any other representations or information in making its investment decision, whether written or oral, relating to the Company, its operations and/or its prospects.

 2.1.6. Accredited Investor. The Purchaser represents that it is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D
under the Securities Act and acknowledges the sale contemplated hereby is being made in reliance on a private placement exemption under the Securities Act only to persons who are to “accredited investors” within the meaning of
Section 501(a) of Regulation D under the Securities Act or similar exemptions under state law. 
 2.1.7. Investment Purposes. The Purchaser is
purchasing the Shares solely for investment purposes, for the Purchaser’s own account and not for the account or benefit of any other person, and not with a view towards the distribution or dissemination thereof. The Purchaser did not decide to
enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule 502 under the Securities Act. 

 2.1.8. Restrictions on Transfer; Shell Company. The Purchaser understands the Shares are being offered in a
transaction not involving a public offering within the meaning of the Securities Act. The Purchaser understands the Shares will be “restricted securities” within the meaning of Rule 144(a)(3) under the Securities Act, and the Purchaser
understands that the certificates or book-entries representing the Shares will contain a legend in respect of such restrictions. If in the future the Purchaser decides to offer, resell, pledge or otherwise transfer the Shares, the Shares may be
offered, resold, pledged or otherwise transferred only pursuant to (i) registration under the Securities Act or (ii) an available exemption from registration. The Purchaser agrees that if any transfer of the Shares or any interest therein
is proposed to be made, as a condition precedent to any such transfer, the Purchaser may be required to deliver to the Company customary representations reasonably satisfactory to the Company. Absent registration or another available exemption from
registration, the Purchaser agrees not to resell the Shares. The Purchaser further acknowledges that because the Company is a shell company, Rule 144 may not be available to the Purchaser for the resale of the Shares until one year has elapsed from
the time that the Company has filed current Form 10-type information with the SEC reflecting its status as an entity that is not a shell company, despite technical compliance with the requirements of Rule 144
and the release or waiver of any contractual transfer restrictions. 
 2.1.9. No Consents. No governmental, administrative or other third party consents or
approvals are required, necessary or appropriate on the part of the Purchaser in connection with the transactions contemplated by this Agreement. 
 2.1.10
Sanctions. The Purchaser is not, and is not owned or controlled by or acting on behalf of a Sanctioned Person (as defined below). The Purchaser is not a non-U.S. shell bank or providing banking services to a non-U.S. shell bank. The Purchaser represents that if it is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.), as amended by the USA PATRIOT Act of 2001 and its
implementing regulations (collectively, the “BSA/PATRIOT Act”), that the Purchaser maintains, either directly or through the use of a third-party administrator, policies and procedures reasonably designed to comply with applicable
obligations under the BSA/PATRIOT Act. The Purchaser also represents that it maintains, either directly or through the use of a third-party administrator, policies and procedures reasonably designed for the screening of any investors against
Sanctions-related lists of blocked or restricted persons. The Purchaser further represents and warrants that, to its best knowledge, the funds held by the Purchaser and used to purchase the Shares are derived from lawful activities. For purposes of
this Agreement, “Sanctioned Person” means at any time any person or entity: (a) listed on any Sanctions-related list of designated or blocked or restricted persons; (b) that is a national of, the government of, or any agency or
instrumentality of the government of, or resident in, or organized under the laws of, a country or territory that is the target of comprehensive Sanctions from time to time (as of the date of this Agreement, Cuba, Iran, North Korea, Syria, and the
Crimea region); or (c) owned or controlled by or acting on behalf of any of the foregoing. “Sanctions” means those trade, economic and financial sanctions laws, regulations, embargoes, and restrictive measures (in each case having the
force of law) administered, enacted or enforced from time to time by (a) the United States (including without limitation the U.S. Department of the Treasury, Office of Foreign Assets Control, the U.S. Department of State, and the U.S.
Department of Commerce), (b) the European Union and enforced by its member states, (c) the United Nations, (d) Her Majesty’s Treasury and (e) the Cayman Islands. 

2.1.11 CFIUS. No foreign person (as defined in 31 C.F.R. Part 800.224) in which the national or subnational governments of a single foreign state have a
substantial interest (as defined in 31 C.F.R. Part 800.244) will acquire a substantial interest in the Company as a result of the purchase and sale of Shares hereunder such that a declaration to the Committee on Foreign Investment in the United
States would be mandatory under 31 C.F.R. Part 800.401, and no foreign person will have control (as defined in 31 C.F.R. Part 800.208) over the Company as a result of the purchase and sale of the Shares hereunder. 

 2.1.12 ERISA. If the Purchaser is an employee benefit plan that is subject to Title I of the Employee
Retirement Income Security Act of 1974, as amended (“ERISA”), a plan, an individual retirement account or other arrangement that is subject to section 4975 of the Internal Revenue Code of 1986, as amended (the “Code”), or an
employee benefit plan that is a governmental plan (as defined in section 3(32) of ERISA), a church plan (as defined in section 3(33) of ERISA), a non-U.S. plan (as described in section 4(b)(4) of ERISA) or
other plan that is not subject to the foregoing but may be subject to provisions under any other federal, state, local, non-U.S. or other laws or regulations that are similar to such provisions of ERISA or the
Code, or an entity whose underlying assets are considered to include “plan assets” of any such plan, account or arrangement (each, a “Plan”) subject to the fiduciary or prohibited Transactions provisions of ERISA or section 4975
of the Code, then the Purchaser represents and warrants that (i) neither the Company, nor any of its respective affiliates (the “Transactions Parties”) has acted as the Plan’s fiduciary, or has been relied on for advice, with
respect to its decision to acquire and hold the Shares, and none of the Transactions Parties shall at any time be relied upon as the Plan’s fiduciary with respect to any decision to acquire, continue to hold or transfer the Shares and
(ii) none of the acquisition, holding and/or transfer or disposition of the Shares will result in a non-exempt prohibited Transactions under ERISA or Section 4975 of the Code or any similar law or
regulation. 
 2.2. Company’s Representations, Warranties and Agreements. To induce the Purchaser to purchase the Shares, the Company hereby represents
and warrants to the Purchaser and agrees with the Purchaser as follows: 
 2.2.1. Organization and Corporate Power. The Company is a Delaware corporation and
is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all
requisite corporate power and authority necessary to enter into this Agreement and to carry out the transactions contemplated by this Agreement. Upon execution and delivery by the Company and the other parties hereto, this Agreement is a legal,
valid and binding agreement of the Company, enforceable against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency, fraudulent conveyance or similar laws affecting the
enforcement of creditors’ rights generally and subject to general principles of equity (regardless of whether enforcement is sought in a proceeding at law or in equity). 

2.2.2. No Conflicts. The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby do
not violate, conflict with or constitute a default under (i) the certificate of incorporation or bylaws of the Company, (ii) any agreement, indenture or instrument to which the Company is a party or by which the Shares are bound or
(iii) any law, statute, rule or regulation to which the Company is or the Shares are subject, or any agreement, order, judgment or decree to which the Company is or the Shares are subject. 

 2.2.3. No Adverse Actions. There are no actions, suits, investigations or proceedings pending, threatened
against or affecting the Company or the Shares which: (i) seek to restrain, enjoin, prevent the consummation of or otherwise affect the transactions contemplated by this Agreement or (ii) question the validity or legality of any
transactions or seeks to recover damages or to obtain other relief in connection with any transactions. 
 2.2.4. No Consents. No governmental,
administrative or other third party consents or approvals are required, necessary or appropriate on the part of the Company in connection with the transactions contemplated by this Agreement. 

2.2.5. More Favorable Terms. Substantially concurrently with the execution of this Agreement, the Company is entering into separate agreements with other
“anchor investors” in respect of the purchase of Shares and the IPO. The Company represents that the material terms of such other agreements (either economic or non-economic) are no more favorable to
such other “anchor investors” thereunder than the terms of this Agreement. For the avoidance of doubt, if any other “anchor investor” has an ability to purchase proportionately more Shares relative to its expression of interest
in the IPO than the Purchaser as set forth on the signature page hereto, then such other “anchor investor” shall be considered to have more favorable material terms than the Purchaser. In the event that another “anchor investor”
is afforded any such more favorable terms than the Purchaser, the Company shall immediately so inform the Purchaser of such more favorable terms, and the Purchaser shall have the right to elect to have such more favorable terms, in which case the
parties hereto shall promptly amend this Agreement to effect the same. Notwithstanding the foregoing, this provision does not apply to any investor that participates in the at-risk capital of the Company via
an investment of $100,000 or more or enters into a formal forward purchase agreement in connection with a private investment in public equity in support of the Company’s initial business combination. For the purposes of this Section 2.2.5,
“at-risk capital” means (i) the Class B Common Stock and (ii) warrants to be issued in a private placement concurrently with the IPO, in each case, to fund IPO costs and working
capital of the Company. 
 2.2.6 Non-Public Information. The Company represents and warrants that none of the
information conveyed to the Purchaser in connection with the transactions contemplated by this Agreement will constitute material non-public information of the Company upon the effectiveness of the
Registration Statement on Form S-1 to be filed by the Company in connection with its IPO (the “Registration Statement”). For the avoidance of doubt, the Purchaser shall not receive any material, non-public information regarding the Company provided by the Company or any of its officers, directors, employees or agents without the Purchaser’s prior written consent. 

2.2.7 Validity of the Shares. Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Shares will be duly and validly issued, fully
paid and non-assessable. 
 2.2.8. Title to the Shares. Upon issuance in accordance with, and payment pursuant to,
the terms hereof, the Purchaser will have or receive good title to the Shares, free and clear of all liens, claims and encumbrances of any kind, other than (a) transfer restrictions hereunder and other agreements to which the Shares may be
subject which have been notified to the Purchaser in writing, (b) transfer restrictions under federal and state securities laws, and (c) liens, claims or encumbrances imposed due to the actions of the Purchaser. 

 3. Forfeiture of Shares. 

3.1. In the event the Purchaser purchases less than the IPO Purchase Amount solely due to the fact that the number of the Units sold in the IPO is reduced
and/or the underwriter[s] of the IPO allocate[s] less Units to the Purchaser than the Purchaser IPO Purchase Amount (the “Alternate IPO Purchase Amount”), then, if the Purchaser purchases the Alternate IPO Purchase Amount, the Purchaser
shall still be entitled to retain the full allocation of Shares as set forth on the signature page hereto. If the Purchaser fails to purchase its allocation of Units, which at no point shall in the aggregate, when taken together with Units purchased
by any Attribution Party of the Purchaser, be higher than 9.90% of the Units sold in the IPO (for the avoidance of doubt, without regard for any Units sold as part of the exercise of the over-allotment option), it shall not be entitled to retain the
Shares and any Shares previously delivered shall be returned and forfeited. For the avoidance of doubt, the Purchaser will not be required to participate in the overallotment option nor any upsizing of the IPO without the Purchaser’s prior
written consent and without first having the opportunity to acquire additional Shares in a manner proportional to any increase in the IPO Purchase Amount at the same price per Share as detailed in the signature page attached hereto. Notwithstanding
the foregoing, the Purchaser acknowledges that the Company and its sponsor may deem it necessary in order to facilitate a business combination for the Company or the sponsor to forfeit, transfer, exchange or amend the terms, or cause the forfeiture,
transfer, exchange or amendment of the terms, of all or any portion of the Class B Common Stock or to enter into any other arrangements with respect to the Class B Common Stock to facilitate the consummation of such business combination,
including voting in favor of any amendment to the terms of the Class B Common Stock (a “Change in Investment”). The Company acknowledges and agrees that any such Change in Investment shall not apply to the Shares. 

3.2. Termination of Rights as Stockholder. If any of the Shares are forfeited in accordance with this Section 3, then after such time the Purchaser (or
successor in interest), shall no longer have any rights as a holder of such forfeited Shares. For the avoidance of doubt, the Shares directly or indirectly owned by the Purchaser shall not be subject to forfeitures (except as described in
Section 3.1 above), surrenders, reductions, mandatory repurchases, redemptions, modifications, cut-backs, claw-backs, transfers, disposals, exchanges or share price vesting triggers commonly known as
“earn-outs” for any reason, including as part of negotiating an initial business combination without the Purchaser’s prior written consent. 

3.3. Share Adjustments. In the event that any adjustment in the number of Shares is required pursuant to this Section 3, the book-entry records for such
Shares shall be reduced accordingly. 
 4. Waiver of Liquidation Distributions; Redemption Rights. In connection with the Shares purchased pursuant to this
Agreement, the Purchaser hereby waives any and all right, title, interest or claim of any kind in or to any distributions by the Company from the trust account which will be established for the benefit of the Company’s public stockholders and
into which substantially all of the proceeds of the IPO will be deposited (the “Trust Account”) in the event of a liquidation of the Company upon the Company’s failure to timely complete an initial business combination. Further, in no
event will the Purchaser have the right to redeem any Shares into funds held in the Trust Account in connection with an initial business combination. For clarity, the Purchaser is not waiving any redemption right or claim to funds held in the trust
account for shares of Class A Common Stock or Units purchased in the IPO or aftermarket (including the IPO Purchase 

 
Amount). In the event the Purchaser purchases shares of Class A Common Stock or Units in the IPO or in the aftermarket (including the IPO Purchase Amount), any shares of Class A Common
Stock or Units so purchased shall be eligible to receive any liquidating distributions by the Company and will have the right to redeem or tender any such shares of Class A Common Stock into funds held in the Trust Account upon the successful
completion of an initial business combination, or any other event that affords public stockholders the right to redeem, and any such redemption shall not result in the forfeiture of any of the Shares. 

5. Restrictions on Transfer. 
 5.1. Securities Law Restrictions.
The Purchaser agrees not to sell, transfer, pledge (other than pledges in the ordinary course of business as part of a prime brokerage arrangement; provided, however, that such pledge does not violate the Securities Act and is otherwise in
compliance with the Lock-up (as defined below)), hypothecate or otherwise dispose of all or any part of the Shares unless, prior thereto (a) a registration statement on the appropriate form under the
Securities Act with respect to the Shares proposed to be transferred shall then be effective or (b) the Company has received customary representations reasonably satisfactory to the Company, that such registration is not required because such
transaction is exempt from registration under the Securities Act and the rules promulgated by the SEC thereunder and from all applicable state securities laws. Notwithstanding the foregoing, the Purchaser may, upon written notice to the Company and
in compliance with securities laws, transfer Shares to an affiliate of the Purchaser who agrees in writing to be bound by the terms of this Agreement. 

5.2. Lock-Up. The Purchaser acknowledges that the Shares will be subject to
lock-up provisions (the “Lock-up”) contained in Section 7 of the Insider Letter filed as an exhibit to the Registration Statement, a copy of which has
been provided to the Purchaser. For the avoidance of doubt, the Purchaser shall not be required to become a party to, and shall not be subject to any other provision of, the Insider Letter except as set forth in this Section 5.2.
Notwithstanding the foregoing, the Purchaser agrees solely with the Company to be subject to the Lock-up contained in Section 7 of the Insider Letter. The Company acknowledges and agrees that any such
agreement limiting the right of the Purchaser to transfer, sell or assign the Shares shall only be between the Purchaser and the Company. 
 5.3. Restrictive
Legends. Any certificates representing the Shares shall have endorsed thereon legends substantially as follows: 
 “THE SECURITIES REPRESENTED HEREBY
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN
EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL, IS AVAILABLE.” 

“THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCKUP AND MAY NOT BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED DURING
THE TERM OF THE LOCKUP.” 

 5.4. Additional Shares or Substituted Securities. In the event of the declaration of a share dividend, the
declaration of an extraordinary dividend payable in a form other than Shares, a spin-off, a share split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the
Company’s outstanding Shares without receipt of consideration, any new, substituted or additional securities or other property which are by reason of such transaction distributed with respect to any Shares subject to this Section 5 or into
which such Shares thereby become convertible shall immediately be subject to this Section 5 and Section 3. Appropriate adjustments to reflect the distribution of such securities or property shall be made to the number and/or class of
Shares subject to this Section 5 and Section 3. 
 5.5. Registration Rights. The Purchaser acknowledges that the Shares are being purchased
pursuant to an exemption from the registration requirements of the Securities Act and will become freely tradable only after certain conditions are met or they are registered pursuant to a registration rights agreement to be entered into with the
Company prior to the closing of the IPO, which registration rights shall be made available by the Company to the Purchaser on terms no less favorable than those afforded to the sponsor and any other pre-IPO
investor in the Company. 
 6. Other Agreements. 
 6.1. Further
Assurances. The parties agree to execute such further instruments and to take such further action as may reasonably be necessary to carry out the intent of this Agreement. 

6.2. Notices. All notices, statements or other documents which are required or contemplated by this Agreement shall be: (i) in writing and delivered
personally or sent by first class registered or certified mail, overnight courier service or facsimile or electronic transmission to the address designated in writing, (ii) by facsimile to the number most recently provided to such party or such
other address or fax number as may be designated in writing by such party and (iii) by electronic mail, to the electronic mail address most recently provided to such party or such other electronic mail address as may be designated in writing by
such party. Any notice or other communication so transmitted shall be deemed to have been given on the day of delivery, if delivered personally or if sent by facsimile or electronic transmission, one (1) business day after delivery to an
overnight courier service or five (5) days after mailing if sent by mail. 
 6.3. Entire Agreement. This Agreement, together with the Insider Letter and
the Registration Rights Agreement, each substantially in the form to be filed as an exhibit to the Registration Statement, embodies the entire agreement and understanding between the Purchaser and the Company with respect to the subject matter
hereof and supersedes all prior oral or written agreements and understandings relating to the subject matter hereof. No statement, representation, warranty, covenant or agreement of any kind not expressly set forth in this Agreement shall affect, or
be used to interpret, change or restrict, the express terms and provisions of this Agreement. 
 6.4. Modifications and Amendments. The terms and provisions
of this Agreement may be modified or amended only by written agreement executed by all parties hereto. 
 6.5. Waivers and Consents. The terms and provisions
of this Agreement may be waived, or consent for the departure therefrom granted, only by a written document executed by the party entitled to the benefits of such terms or provisions. No such waiver or consent shall be deemed to be or shall
constitute a waiver or consent with respect to any other terms or provisions of this Agreement, whether or not similar. Each such waiver or consent shall be effective only in the specific instance and for the purpose for which it was given, and
shall not constitute a continuing waiver or consent. 

 6.6. Assignment. The rights and obligations under this Agreement may not be assigned by either party hereto
without the prior written consent of the other party. 
 6.7. Benefit. All statements, representations, warranties, covenants and agreements in this
Agreement shall be binding on the parties hereto and shall inure to the benefit of the respective successors and permitted assigns of each party hereto. Nothing in this Agreement shall be construed to create any rights or obligations except among
the parties hereto, and no person or entity shall be regarded as a third-party beneficiary of this Agreement. 
 6.8. Governing Law. This Agreement and the
rights and obligations of the parties hereunder shall be construed in accordance with and governed by the laws of New York applicable to contracts wholly performed within the borders of such state, without giving effect to the conflict of law
principles thereof. 
 6.9. Severability. In the event that any court of competent jurisdiction shall determine that any provision, or any portion thereof,
contained in this Agreement shall be unreasonable or unenforceable in any respect, then such provision shall be deemed limited to the extent that such court deems it reasonable and enforceable, and as so limited shall remain in full force and
effect. In the event that such court shall deem any such provision, or portion thereof, wholly unenforceable, the remaining provisions of this Agreement shall nevertheless remain in full force and effect. 

6.10. No Waiver of Rights, Powers and Remedies. No failure or delay by a party hereto in exercising any right, power or remedy under this Agreement, and no
course of dealing between the parties hereto, shall operate as a waiver of any such right, power or remedy of such party. No single or partial exercise of any right, power or remedy under this Agreement by a party hereto, nor any abandonment or
discontinuance of steps to enforce any such right, power or remedy, shall preclude such party from any other or further exercise thereof or the exercise of any other right, power or remedy hereunder. The election of any remedy by a party hereto
shall not constitute a waiver of the right of such party to pursue other available remedies. No notice to or demand on a party not expressly required under this Agreement shall entitle the party receiving such notice or demand to any other or
further notice or demand in similar or other circumstances or constitute a waiver of the rights of the party giving such notice or demand to any other or further action in any circumstances without such notice or demand. 

6.11. Survival of Representations and Warranties. All representations and warranties made by the parties hereto in this Agreement or in any other agreement,
certificate or instrument provided for or contemplated hereby, shall survive the execution and delivery hereof and any investigations made by or on behalf of the parties. 

6.12. No Broker or Finder. Each of the parties hereto represents and warrants to the other that no broker, finder or other financial consultant has acted on
its behalf in connection with this Agreement or the transactions contemplated hereby in such a way as to create any liability on the other. Each of the parties hereto agrees to indemnify and save the other harmless from any claim or demand for
commission or other compensation by any broker, finder, financial consultant or similar agent claiming to have been employed by or on behalf of such party and to bear the cost of legal expenses incurred in defending against any such claim. 

 6.13. Headings and Captions. The headings and captions of the various subdivisions of this Agreement are for
convenience of reference only and shall in no way modify or affect the meaning or construction of any of the terms or provisions hereof. 
 6.14.
Counterparts. This Agreement may be executed in one or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to
the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or any other form of electronic delivery, such signature shall create a valid and
binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such signature page were an original thereof. 

6.15. Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or
interpretation arises, this Agreement will be construed as if drafted jointly by the parties hereto and no presumption or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any provision of this
Agreement. The words “include,” “includes,” and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine, and neuter genders will be construed to include any other
gender, and words in the singular form will be construed to include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,” “hereby,”
“hereunder,” and words of similar import refer to this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each representation, warranty, and covenant contained herein will
have independent significance. If any party hereto has breached any representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter
(regardless of the relative levels of specificity) which such party hereto has not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty, or covenant. 

7. Voting and Tender of Shares. The Purchaser agrees solely with the Company to vote the Shares in favor of an initial business combination that the Company
negotiates and submits for approval to the Company’s stockholders. Additionally, the Purchaser agrees solely with the Company not to tender any Shares in connection with a tender offer presented to the Company’s stockholders in connection
with an initial business combination negotiated by the Company. For clarity, in the event the Purchaser purchases shares of Class A Common Stock in the IPO or in the aftermarket (including the IPO Purchase Amount), the Purchaser retains the
right to tender any such shares of Class A Common Stock so purchased in connection with a tender offer. In addition, there shall be no limitation on the Purchaser’s right to (i) redeem or tender any such shares of Class A Common
Stock into funds held in the Trust Account upon the successful completion of an initial business combination, or any other event that affords public stockholders the right to redeem or (ii) otherwise sell, assign or transfer of any securities
of the Company (other than the Shares) prior to the closing of the initial business combination. For the avoidance of doubt, the foregoing agreement that the Purchaser vote all of the Shares in favor of such proposed initial business combination
shall only be between the Purchaser and the Company. 

 8. Indemnification. Each party shall indemnify the other against any loss, cost or damages (including
reasonable and documented out-of-pocket attorney’s fees and expenses) incurred as a result of such party’s breach of any representation, warranty, covenant or
agreement in this Agreement. 
 9. No Publicity. The Company shall not (and shall cause the sponsor and its other affiliates, officers, directors, employees
and agents not to) publicly disclose the name of the Purchaser or any affiliate or investment advisor of the Purchaser or include the name of the Purchaser or any affiliate or investment advisor of the Purchaser without the prior written consent
(which consent may be in the form of electronic mail) of the Purchaser (i) in any press release or marketing materials or (ii) in any filing with the SEC or any regulatory agency or trading market, except (A) as required by the
federal securities laws, rules or regulations, (B) to the extent such disclosure is required by other laws, rules or regulations, at the request of the staff of the SEC or regulatory agency or under regulations of any national securities
exchange on which the Company’s securities are listed for trading or (C) to the extent such announcements or other communications contain only information previously disclosed in a public statement, press release or other communications
previously approved in accordance with this Section 9, in which case the Company shall provide the Purchaser with prior written notice of such disclosure permitted under subclauses (A) through (C) and shall reasonably consult with the
Purchaser regarding such disclosure and consider, in good faith, any comments provided by the Purchaser. 
 10. Termination. In the event (i) the
IPO is not consummated by December 31, 2021 or (ii) there is a change in the structure of the IPO, the capitalization of the Company, the composition of the Company’s executive officers or the underwriters of the IPO, all as
disclosed in the Company’s Registration Statement on the Form S-1, the Company shall promptly refund to the Purchaser any previously funded Purchase Price in accordance with the instructions provided by
the Purchaser and the Shares will not be delivered to the Purchaser. 
 [Signature Page Follows] 

 If the foregoing accurately sets forth our understanding and agreement, please sign the enclosed copy of
this Agreement and return it to us. 
  

	
	Very truly yours,
	
	TRAJECTORY ALPHA ACQUISITION CORP.
	
	By:____________________________
	      Name:
	      Title:
	
	Purchaser: ____________________________
	
	Address: ____________________________
	
	E-mail: ____________________________
	
	Phone: _______________________________
	
	Attention: ____________________________
	
	Number of Shares of Class B Common Stock Purchased: _____________
	
	Aggregate Purchase Price: $_______________
	
	IPO Units: __________________
	
	By:____________________________
	      Name:
	      Title:

 [Trajectory Alpha Acquisition Corp.—Signature Page to Securities Purchase Agreement]Exhibit 10.1

    

     

      

    Execution Version

      

     

      STOCK PURCHASE AGREEMENT

       

      This Stock Purchase Agreement (this “Agreement”)

        is dated as of December 15, 2021, between Venus Concept Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages
        hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

       

      WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to Section 4(a)(2) of the Securities Act of
        1933, as amended (the “Securities Act”), and Rule 506 promulgated thereunder, the Company desires to issue and sell to each Purchaser, and each Purchaser,
        severally and not jointly, desires to purchase from the Company, securities of the Company as more fully described in this Agreement.

       

      NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
        the receipt and adequacy of which are hereby acknowledged, the Company and each Purchaser agree as follows:

       

      ARTICLE I.

        DEFINITIONS

       

       1.1.          Definitions.  In addition to the terms defined elsewhere in this Agreement: (a) capitalized terms that are not otherwise defined herein have the meanings given
          to such terms in the Certificate of Designation (as defined herein); and (b) the following terms have the meanings set forth in this Section 1.1:

       

      “Acquiring Person” shall have the meaning
        ascribed to such term in Section 4.6.

       

      “Affiliate” means any Person that, directly
        or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person, as such terms are used in and construed under Rule 405 under the Securities Act.

       

      “Agreement” shall have the meaning ascribed
        to such term in the Preamble.

       

      “Anti-Corruption Laws” means any laws,
        rules, or regulations relating to bribery or corruption, including without limitation the Foreign Corrupt Practices Act and UK Bribery Act.

       

      “Anti-Terrorism Laws” means any laws,
        rules, regulations or orders relating to terrorism, sanctions or money laundering, including without limitation Executive Order No. 13224 (effective September 24, 2001), the USA PATRIOT Act, the laws comprising or implementing the Bank Secrecy Act,
        and the laws administered by OFAC.

       

       “Blocked Person” means any Person: (a)
        listed in the annex to, or is otherwise subject to the provisions of, Executive Order No. 13224; (b) a Person owned or controlled by, or acting for or on behalf of, any Person that is listed in the annex to, or is otherwise subject to the
        provisions of, Executive Order No. 13224; (c) a Person with which any Purchaser is prohibited from dealing or otherwise engaging in any transaction by any Anti-Terrorism Law; (d) a Person that commits, threatens or conspires to commit or supports
        “terrorism” as defined in Executive Order No. 13224; or (e) a Person that is named a “specially designated national” or “blocked person” on the most current list published by OFAC or other similar list.

       

      “Board of Directors” means the board of
        directors of the Company.

       

      “Business Day” means any day except any
        Saturday, any Sunday, any day which is a federal legal holiday in the United States or any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.

       

      “Capital Stock” means, for any entity, any
        and all shares, interests, rights to purchase, warrants, options, participations or other equivalents of or interests in (however designated) stock issued by that entity, but shall not include any debt securities convertible into or exchangeable
        for any securities otherwise constituting Capital Stock pursuant to this definition.  Unless the context otherwise requires, Capital Stock shall refer to Capital Stock of the Company.

       

      
        
          

      

      
      “Certificate of Designation” means the
        Certificate of Designation to be filed prior to the Closing by the Company with the Secretary of State of the State of Delaware, in the form of Exhibit A
        attached hereto.

       

      “Closing” means the sale of the Closing
        Shares pursuant to Section 2.1.

       

      “Closing Date” means the date hereof,
        assuming all of the Transaction Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (a) the Purchasers’ obligations to pay the Subscription Amount and (b) the Company’s obligations to
        deliver the Closing Shares, in each case, have been satisfied or waived.

       

      “Closing Shares” means the shares of Common
        Stock and Nonvoting Convertible Preferred Stock sold in the Closing.

       

      “Commission” means the United States
        Securities and Exchange Commission.

       

      “Common Stock” means the common stock of
        the Company, par value $0.0001 per share, and any other class of securities into which such securities may hereafter be reclassified or changed; provided,
        that if the context so requires, “Common Stock” shall mean such shares of Common Stock sold in the Closing.

       

      “Common Stock Equivalents” means any
        securities of the Company which would entitle the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant or other instrument that is at any time convertible into or
        exercisable or exchangeable for, or otherwise entitles the holder thereof to receive, Common Stock.

       

      “Company” shall have the meaning ascribed
        to such term in the Preamble.

       

      “Company Counsel” means Dorsey &
        Whitney LLP, with offices located at Brookfield Place, 161 Bay Street, Suite 4310, Toronto, ON M5J 2S1.

       

      “Effective Date” means the earliest of the
        date that (a) the initial Registration Statement has been declared effective by the Commission, (b) all of the Common Stock and Underlying Shares have been sold pursuant to Rule 144 or may be sold pursuant to Rule 144 without the requirement for
        the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions, (c) following the one year anniversary of the Closing Date, provided that a holder of Common Stock or
        Underlying Shares is not an Affiliate of the Company, or (d) all of the Common Stock and Underlying Shares may be sold pursuant to an exemption from registration under Section 4(1) of the Securities Act without volume or manner-of-sale restrictions
        and Company Counsel has delivered to such holders a standing written unqualified opinion that resales may then be made by such holders of the Common Stock and Underlying Shares pursuant to such exemption which opinion shall be in form and substance
        reasonably acceptable to such holders.

       

      “Exchange Act” means the Securities
        Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.

       

      “Exchange Act Reports” shall have the
        meaning ascribed to such term in Section 3.1(j).

       

      “FCPA” means the Foreign Corrupt Practices
        Act of 1977, as amended.

       

      “FDA” means the Food and Drug
        Administration.

       

      “GAAP” means generally accepted accounting
        principles set forth in the opinions and pronouncements of the Accounting Principles Board of the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or in such other
        statements by such other Person as may be approved by a significant segment of the accounting profession in the United States, which are applicable to the circumstances as of the date of determination.

       

      
        -2-

        
          

      

      “Governmental Approval” means any consent,
        authorization, approval, order, license, franchise, permit, certificate, accreditation, registration, filing or notice, of, issued by, from or to, or other act by or in respect of, any Governmental Authority.

       

      “Governmental Authority” means any nation
        or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body (including, without limitation, the FDA), court, central bank or other entity exercising executive, legislative, judicial,
        taxing, regulatory or administrative functions of or pertaining to government, any securities exchange and any self-regulatory organization.

       

      “Intellectual Property” means any and all
        U.S. or foreign patents, patent applications, copyrights and copyright registrations and applications, inventions, invention disclosures, protected formulae, formulations or processes, trade secrets and other similar intellectual property rights.

       

      “Investor Rights Agreement” means the
        Investor Rights Agreement, dated the date hereof, among the Company and the Purchasers, in the form of Exhibit C attached hereto.

       

      “Knowledge” means, in reference to the
        Company, the actual knowledge, or the actual knowledge that would be obtained following reasonable investigation, of any of the President, Chief Executive Officer, or Chief Financial Officer of the Company

       

      “Liens” means a lien, charge pledge,
        security interest, encumbrance, right of first refusal, preemptive right or other similar restriction.

       

      “Material Adverse Effect” means a material
        adverse change in the business, operations or condition (financial or otherwise) of the Company and its Subsidiaries, when taken as a whole; provided that the impacts of COVID-19 on the operations, business or financial condition of the Issuer or
        any of its Subsidiaries that occurred and were disclosed to the Purchasers as of the Effective Date or otherwise publicly available on or prior to the Effective Date will be disregarded.

       

      “Material Agreement” means any license,
        agreement or other contractual arrangement required to be disclosed (including amendments thereto) under regulations promulgated under the Securities Act or the Exchange Act, as may be amended; provided, however, that “Material Agreements” shall
        exclude all real estate leases and all employee or director compensation agreements, arrangements or plans, or any amendments thereto.

       

      “Maximum Rate” shall have the meaning
        ascribed to such term in Section 5.17.

       

      “Nonvoting Convertible Preferred Stock”
        means the 3,790,755 shares of the Company’s Nonvoting Convertible Preferred Stock issued hereunder, having the rights, preferences and privileges set forth in the Certificate of Designation, in the form of Exhibit A hereto.

       

      “OFAC” means the U.S. Department of
        Treasury Office of Foreign Assets Control.

       

      “Open Source Licenses” shall have the
        meaning ascribed to such term in Section 3.1(b).

       

      “Permitted Liens” means any security
        interest in favor of (a) Madryn Health Partners, LP or the other secured parties pursuant to that certain Guaranty and Security Agreement, dated as of December 9, 2020, as amended, by and among the Company, Madryn Health Partners, LP and the other
        parties thereto or (b) City National Bank of Florida pursuant to that certain Security Agreement, dated as of March 20, 2020, as amended, by and among the Company and City National Bank of Florida.

       

      
        -3-

        
          

      

      “Person” means an individual or
        corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

       

      “Proceeding” means an action, claim, suit,
        investigation or proceeding (including, without limitation, an informal investigation or partial proceeding, such as a deposition), whether commenced or threatened.

       

      “Purchaser” shall have the meaning ascribed
        to such term in the Preamble.

       

      “Purchaser Party” shall have the meaning
        ascribed to such term in Section 4.9.

       

      “Registration Rights Agreement” means the
        Registration Rights Agreement, dated the date hereof, among the Company and the Purchasers, in the form of Exhibit B attached hereto.

       

      “Registration Rights Waivers” shall have
        the meaning ascribed to such term in Section 2.2(a)(vii).

       

      “Registration Statement” means a
        registration statement meeting the requirements set forth in the Registration Rights Agreement and covering the resale by the Purchasers of the Common Stock and the Underlying Shares.

       

      “Required Minimum” means, as of any date,
        the maximum aggregate number of shares of Common Stock then issued or potentially issuable in the future pursuant to the Transaction Documents, including the Underlying Shares issuable upon conversion in full of all shares of Nonvoting Convertible
        Preferred Stock, ignoring any conversion limits set forth therein.

       

      “Requirement of Law” means as to any
        Person, the organizational or governing documents of such Person, and any law (statutory or common), treaty, rule or regulation or determination of an arbitrator or a court or other Governmental Authority, in each case applicable to or binding upon
        such Person or any of its property or to which such Person or any of its property is subject.

       

      “Rule 144” means Rule 144 promulgated by
        the Commission pursuant to the Securities Act, as such Rule may be amended or interpreted from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same purpose and effect as such Rule.

       

      “Securities” means the Common Stock, the
        Nonvoting Convertible Preferred Stock and the Underlying Shares.

       

      “Securities Act” shall have the meaning
        ascribed to such term in the Preamble.

       

      “Short Sales” means all “short sales” as
        defined in Rule 200 of Regulation SHO under the Exchange Act (but shall not be deemed to include the location and/or reservation of borrowable shares of Common Stock).

       

      “Solvent” means, with respect to any
        Person, that (a) the fair salable value of such Person’s consolidated assets exceeds the fair value of such Person’s liabilities, (b) the fair salable value of such Person’s consolidated property exceeds the fair value of such Person’s liabilities,
        (c) such Person is not left with unreasonably small capital giving effect to the transactions contemplated by this Agreement and the other Transaction Documents, and (d) such Person is able to pay its debts (including trade debts) as they become
        due (whether at maturity or otherwise) (without taking into account any forbearance and extensions related thereto).

       

      “Subscription Amount” means, as to each
        Purchaser, the aggregate amount to be paid for Common Stock and Nonvoting Convertible Preferred Stock purchased hereunder in the Closing as specified below such Purchaser’s name on the signature page of this Agreement and next to the heading
        “Subscription Amount,” in United States dollars and in immediately available funds.

       

      “Subsidiary” means any wholly owned
        subsidiary of the Company.

       

      
        -4-

        
          

      

      “Taxes” means all present or future taxes,
        levies, imposts, duties, deductions, withholdings (including backup withholding), assessments, fees or other charges imposed by any Governmental Authority, including any interest, additions to tax or penalties applicable thereto.

       

      “Technology” means, collectively, all
        Software, information, designs, formulae, algorithms, procedures, methods, techniques, ideas, know-how, research and development, technical data, programs, subroutines, tools, materials, specifications, processes, inventions (whether patentable or
        unpatentable and whether or not reduced to practice), apparatus, creations, improvements, works of authorship and other similar materials, and all recordings, graphs, drawings, reports, analyses, and other writings, and other tangible embodiments
        of the foregoing, in any form whether or not specifically listed herein, and all related technology, that are used in, incorporated in, embodied in, displayed by or relate to, or are used in connection with the foregoing.

       

      “Trademarks” means any trademarks, service
        mark rights, trade names and other identifiers indicating the business or source of goods or services, whether registered or not, applications to register and registrations of the same and like protections, and the entire goodwill of the business
        of the Company and each of its Subsidiaries connected with and symbolized by such trademarks.

       

      “Trading Day” means a day on which the
        principal Trading Market is open for trading.

       

      “Trading Market” means any of the following
        markets or exchanges on which the Common Stock is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the Nasdaq Global Select Market, or the New York Stock Exchange (or any
        successors to any of the foregoing).

       

      “Transaction Documents” means this
        Agreement, the Certificate of Designation, the Registration Rights Agreement, the Investor Rights Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements executed in connection with the transactions
        contemplated hereunder.

       

      “Transfer Agent” means Computershare Inc.,
        the current transfer agent of the Corporation, with a mailing address of 250 Royall Street, Canton, Massachusetts 02021, and any successor transfer
        agent of the Corporation.

       

      “Underlying Shares” means the shares of
        Common Stock issuable upon conversion of the Nonvoting Convertible Preferred Stock issued hereunder.

       

      ARTICLE II.

        PURCHASE AND SALE

       

       2.1.          Closing.

       

      On the Closing Date, upon the terms and subject to the conditions set forth herein, substantially concurrent with the execution and
        delivery of this Agreement by the parties hereto and in any event on or prior to December 15, 2021, the Company agrees to sell, and the Purchasers, severally and not jointly, agree to purchase, the number of shares of Common Stock and Nonvoting
        Convertible Preferred Stock as set forth on Schedule 2.1. Each Purchaser acquiring shares of Common Stock and Nonvoting Convertible Preferred Stock at the
        Closing shall deliver to the Company, via wire transfer, immediately available funds equal to its Subscription Amount pursuant to Section 2.2(b)(ii), and the Company shall deliver to each Purchaser its respective shares of Common Stock and
        Nonvoting Convertible Preferred Stock, and the Company and each Purchaser shall deliver the other items set forth in Section 2.2 deliverable at the Closing. Upon satisfaction of the covenants and conditions set forth in Sections 2.2 and 2.3, the
        Closing shall occur remotely.

       

      
        -5-

        
          

      

       2.2.          Deliveries.

       

      (a)          On or prior to the
          Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following:

       

      (i)          this
          Agreement duly executed by the Company;

       

      (ii)          for
          each Purchaser, evidence of a book entry transfer evidencing a number of shares of Common Stock and Nonvoting Convertible Preferred Stock as set forth on Schedule
              2.1, registered in the name of such Purchaser, and evidence of the filing and acceptance of the Certificate of Designation from the Secretary of State of the State of Delaware;

       

      (iii)          the

          Company shall have provided each Purchaser with the Company’s wire instructions;

       

      (iv)          the
          Registration Rights Agreement duly executed by the Company;

       

      (v)          the
          Investor Rights Agreement duly executed by the Company; and

       

      (vi)          a
          legal opinion of Company Counsel, substantially in the form of Exhibit D attached hereto.

       

      (b)          On or prior to the
          Closing Date, each Purchaser shall deliver or cause to be delivered to the Company the following:

       

      (i)          this
          Agreement duly executed by such Purchaser;

       

      (ii)          such

          Purchaser’s Subscription Amount by wire transfer to the account specified in writing by the Company;

       

      (iii)          the

          Registration Rights Agreement duly executed by such Purchaser;

       

      (iv)          an
          “accredited investor” questionnaire, in a form acceptable to the Company in its reasonable discretion, duly executed by such Purchaser; and

       

      (v)          the
          Investor Rights Agreement duly executed by such Purchaser.

       

       2.3.          Closing Conditions.

       

      (a)          The obligations of the
          Company hereunder in connection with the Closing are subject to the following conditions being met:

       

      (i)          the
          accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) on the Closing Date of the representations and warranties of the Purchasers contained
          herein (unless as of a specific date therein in which case they shall be accurate as of such date);

       

      (ii)          all
          obligations, covenants and agreements of each Purchaser required to be performed at or prior to the Closing Date shall have been performed; and

       

      (iii)          the

          delivery by each Purchaser of the items set forth in Section 2.2(b) of this Agreement.

          

      

       

      
        -6-

        
          

      

      (b)          The respective
          obligations of the Purchasers hereunder in connection with the Closing are subject to the following conditions being met:

       

      (i)          the
          accuracy in all material respects (or, to the extent representations or warranties are qualified by materiality or Material Adverse Effect, in all respects) when made and on the Closing Date of the representations and warranties of the Company
          contained herein (unless as of a specific date therein in which case they shall be accurate as of such date);

       

      (ii)          all
          obligations, covenants and agreements of the Company required to be performed at or prior to the Closing Date shall have been performed;

       

      (iii)          the

          delivery by the Company of the items set forth in Section 2.2(a) of this Agreement;

       

      (iv)          there

          shall have been no Material Adverse Effect with respect to the Company since the date hereof; and

       

      (v)          from
          the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended by the Commission or the Company’s principal Trading Market, and, at any time prior to the Closing Date, trading in securities generally as reported by
          Bloomberg L.P. shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Trading Market, nor shall a banking moratorium have been declared either
          by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material adverse change in,
          any financial market which, in each case, in the reasonable judgment of such Purchaser, makes it impracticable or inadvisable to purchase the Closing Shares at the Closing.

       

      ARTICLE III.

        REPRESENTATIONS AND WARRANTIES

       

       3.1.          Representations and Warranties of the Company.  The Company hereby makes the following representations and warranties to each Purchaser, except as disclosed in
          the Company’s filings with the Commission following December 31, 2020 (with respect to such filings, excluding any disclosures set forth in any risk factors or “forward looking statements” within the meaning of the Securities Act):

       

      (a)          Due Organization, Authorization: Power and Authority.  The Company and each of its Subsidiaries is duly existing and in good standing in its
          jurisdictions of organization or formation and the Company and each of its Subsidiaries is qualified and licensed to do business and is in good standing in any jurisdiction in which the conduct of its businesses or its ownership of property
          requires that it be so qualified except where the failure to do so could not reasonably be expected to have a Material Adverse Effect.

       

      The execution, delivery and performance by the Company of the Transaction Documents to which it is a party do not and will not (i)
        conflict with the Company’s or any of its Subsidiaries’ organizational documents, including their respective certificate of incorporation and bylaws, (ii) contravene, conflict with, constitute a default under or violate any material Requirement of
        Law applicable thereto, (iii) contravene, conflict or violate any applicable order, writ, judgment, injunction, decree, determination or award of any Governmental Authority by which the Company, or any of its property or assets may be bound or
        affected, (iv) require any action by, filing, registration, notice to or qualification with, or Governmental Approval from, any Governmental Authority or any other Person (except for such Governmental Approvals which have already been obtained and
        are in full force and effect), or (v) constitute an event of default or material breach under any Material Agreement by which the Company, any of its Subsidiaries or any of their respective properties, is bound.  Neither the Company nor any of its
        Subsidiaries is in default or material breach under any Material Agreement to which it is a party or by which it or any of its assets is bound in which such default could reasonably be expected to have a Material Adverse Effect.

       

      
        -7-

        
          

      

      The Company has the requisite corporate power and authority to enter into and to consummate the transactions contemplated by this
        Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.  The execution and delivery of each of this Agreement and the other Transaction Documents by the Company and the consummation
        of the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company, the Board of Directors or the Company’s stockholders in connection
        herewith or therewith.

       

      (b)          Intellectual Property.  The Company and each of its Subsidiaries is the sole owner of the Intellectual Property each respectively purports to own, free and clear of all Liens,
          other than Permitted Liens, and non-exclusive licenses for off-the-shelf software that is commercially available to the public.

       

      None of the Company or any of its Subsidiaries has used any software or other materials that are subject to an open-source or similar
        license (including the General Public License, Lesser General Public License, Mozilla Public License, or Affero License) (collectively, “Open Source Licenses”) in a manner that would cause any software or other materials owned by the Company or
        used in any Company products to have to be (i) distributed to third parties at no charge or a minimal charge, (ii) licensed to third parties for the purpose of creating modifications or derivative works, or (iii) subject to the terms of such Open
        Source License.

       

      Each employee and contractor of the Company and its Subsidiaries involved in development or creation of any material Intellectual
        Property has assigned any and all inventions and ideas of such Person in and to such Intellectual Property to the Company or such Subsidiary, except where failure to do so could not reasonably be expected to have a Material Adverse Effect, in each
        case individually or in the aggregate.

       

      No settlement or consents, covenants not to sue, nonassertion assurances, or releases have been entered into by the Company or any of
        its Subsidiaries or exist to which the Company or such Subsidiary is bound that adversely affect its rights to own or use any Intellectual Property except as could not be reasonably expected to result in a Material Adverse Effect, in each case
        individually or in the aggregate.

       

      (c)          Subsidiaries’ Equity Interests. Except as set forth on Schedule 3.1(c), all of the issued ownership interests
          of each of the Subsidiaries of the Company are duly authorized and validly issued, fully paid, nonassessable, and directly owned by the Company or its applicable Subsidiary and are free and clear of all Liens, other than Permitted Liens, and not
          subject to any preemptive rights, rights of first refusal, option, warrant, call, subscription, and similar rights, other than as required by law.

       

      (d)          Litigation.  There are no actions, suits, investigations, or proceedings pending or, to the Company’s Knowledge, threatened in writing by or against the Company or any of its
          Subsidiaries reasonably expected to result in the payment or award of damages of more than Five Hundred Thousand Dollars ($500,000.00).

       

      (e)          No Broker’s Fees.  None of the Company nor any of its Subsidiaries are party to any contract, agreement or understanding with any Person that would give rise to a valid claim
          against them or the Purchasers for a brokerage commission, finder’s fee or like payment in connection with the Transaction Documents and the transactions contemplated thereby.

       

      (f)          No Material Adverse Effect; Financial Statements.  All consolidated financial statements for the Company and its consolidated Subsidiaries, delivered to the Purchasers fairly
          present, in conformity with GAAP, and in all material respects the consolidated financial condition of the Company and its consolidated Subsidiaries, and the consolidated results of operations of the Company and its consolidated Subsidiaries as
          of and for the dates presented.  Since December 31, 2020, there has not been a Material Adverse Effect.

       

      (g)          No General Solicitation.  Neither the Company nor any of its Subsidiaries or any of their affiliates (as defined in Rule 501(b) of Regulation D) or any person or entity acting
          on its or their behalf has engaged directly or indirectly in any form of general solicitation or general advertising (within the meaning of Rule 502(c) of Regulation D) in connection with the offering, issuance and sale of the Common Stock and
          Nonvoting Convertible Preferred Stock in any manner involving a public offering within the meaning of Section 4(a)(2) of the Securities Act.

       

      
        -8-

        
          

      

      (h)          Accredited Investors.  Neither the Company nor any of its Subsidiaries has offered or sold any of the Closing Shares to any person or entity whom it reasonably believes is not
          an “accredited investor” (as defined in Rule 501(a) of Regulation D).

       

      (i)          Solvency.  The Company is, and upon consummation of the transactions contemplated by the Transaction Documents will be, Solvent.  The Company and each of its Subsidiaries, when
          taken as a whole, is, and upon consummation of the transactions contemplated by the Transaction Documents will be, Solvent.

       

      (j)          Exchange Act Compliance.  All documents filed with the Commission by the Company under the Exchange Act are hereinafter referred to herein as the “Exchange Act Reports”.  The
          Exchange Act Reports, when they were or are filed with the Commission, conformed or will conform in all material respects to the applicable requirements of the Exchange Act and the applicable rules and regulations of the Commission thereunder. 
          The Exchange Act Reports did not, when filed with the Commission, contain an untrue statement of material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they
          were made, not misleading.

       

      (k)          Regulatory Compliance.  Neither the Company nor any of its Subsidiaries is an “investment company” or a company “controlled” by an “investment company” under the Investment
          Company Act of 1940, as amended.  Neither the Company nor any of its Subsidiaries is engaged as one of its important activities in extending credit for margin stock (under Regulations X, T and U of the Federal Reserve Board of Governors).  The
          Company and each of its Subsidiaries complies in all material respects with the Federal Fair Labor Standards Act.  Neither the Company nor any of its Subsidiaries is a “holding company” or an “affiliate” of a “holding company” or a “subsidiary
          company” of a “holding company” as each term is defined and used in the Public Utility Holding Company Act of 2005.  Neither the Company nor any of its Subsidiaries has violated any laws, order, ordinances or rules, the violation of which could
          reasonably be expected to have a Material Adverse Effect.  Neither the Company’s nor any of its Subsidiaries’ properties or assets has been used by the Company or such Subsidiary or, to the Company’s Knowledge, by previous Persons, in disposing,
          producing, storing, treating, or transporting any hazardous substance other than in material compliance with material applicable laws.  The Company and each of its Subsidiaries has obtained all material consents, approvals and authorizations of,
          made all declarations or filings with, and given all notices to, all Governmental Authorities that are necessary to continue their respective businesses as currently conducted.

       

      None of the Company, any of its Subsidiaries, or any of the Company’s or its Subsidiaries’ Affiliates or any of their respective
        agents acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement is (i) in violation of any Anti-Terrorism Law or Anti-Corruption Law, (ii) engaging in or conspiring to engage in any transaction that
        evades or avoids, or has the purpose of evading or avoiding or attempts to violate, any of the prohibitions set forth in any Anti-Terrorism Law or Anti-Corruption Law, or (iii) is a Blocked Person.  None of the Company, any of its Subsidiaries, or
        to the Knowledge of the Company, any of their Affiliates or agents, acting or benefiting in any capacity in connection with the transactions contemplated by this Agreement, (x) conducts any business or engages in making or receiving any
        contribution of funds, goods or services to or for the benefit of any Blocked Person, or (y) deals in, or otherwise engages in any transaction relating to, any property or interest in property blocked pursuant to Executive Order No. 13224, any
        similar executive order or other Anti-Terrorism Law.

       

      (l)          Tax Returns and Payments; Pension Contributions.  The Company and each of its Subsidiaries have timely filed all required tax returns and reports (or extensions thereof), and
          the Company and each of its Subsidiaries, have timely paid all foreign, federal, state, and local Taxes, assessments, deposits and contributions owed by the Company and such Subsidiaries in a cumulative amount greater than One Hundred Thousand
          Dollars ($100,000), in all jurisdictions in which the Company or any such Subsidiary is subject to Taxes, including the United States, unless such Taxes are being contested in accordance with the next sentence.  The Company and each of its
          Subsidiaries, may defer payment of any contested Taxes, provided that the Company or such Subsidiary, (a) in good faith contests its obligation to pay the Taxes by appropriate proceedings promptly and diligently instituted and conducted; and (b)
          maintains adequate reserves or other appropriate provisions on its books in accordance with GAAP.  Neither the Company nor any of its Subsidiaries is aware of any claims or adjustments proposed for any of the Company’s or such Subsidiary’s, prior
          Tax years which could result in additional taxes in a cumulative amount greater than One Hundred Thousand Dollars ($100,000) becoming due and payable by the Company or its Subsidiaries.  The Company and each of its Subsidiaries have paid all
          amounts necessary to fund all present pension, profit sharing and deferred compensation plans in accordance with their terms, and neither the Company nor any of its Subsidiaries has, withdrawn from participation in, has permitted partial or
          complete termination of, or has permitted the occurrence of any other event with respect to, any such plan which could reasonably be expected to result in any liability of the Company or its Subsidiaries, including any liability to the Pension
          Benefit Guaranty Corporation or its successors or any other Governmental Authority.

       

      
        -9-

        
          

      

      (m)          Full Disclosure.  No written representation, warranty or other statement of the Company or any of its Subsidiaries in any certificate or written statement, when taken as a
          whole, given to any Purchaser, as of the date such representation, warranty, or other statement was made, taken together with all such written certificates and written statements given to any Purchaser, contains any untrue statement of a material
          fact or omits to state a material fact necessary to make the statements contained in the certificates or statements not misleading (it being recognized that projections and forecasts provided by the Company in good faith and based upon reasonable
          assumptions are not viewed as facts and that actual results during the period or periods covered by such projections and forecasts may differ from the projected or forecasted results).

       

      (n)          Enforceability.  The Transaction Documents have been duly executed by the Company and, upon the consummation of the transactions contemplated by the Transaction Documents, shall
          constitute the legal, valid, and binding obligations of the Company, enforceable against the Company in accordance with their terms, except as such enforceability may be limited by bankruptcy, fraudulent conveyance, insolvency, reorganization,
          transfer, moratorium, and other laws relating to or affecting creditors’ rights generally and by general equitable principles (regardless of whether such enforceability is considered in a proceeding in equity or at law).

       

      (o)          Valid Issuance.  The Closing Shares (a) have been duly authorized by the Company and, upon their issuance pursuant to this Agreement in accordance with Section 2.1, will be
          validly issued, fully paid and non-assessable, (b) will not, as of each applicable Closing Date, be subject to any preemptive, participation, rights of first refusal or other similar rights, and (c) assuming the accuracy of each Purchaser’s
          representations and warranties hereunder, (i) will be issued exempt from the registration requirements of the Securities Act pursuant to Section 4(a)(2) of the Securities Act and (ii) will be issued in compliance with all applicable state and
          federal laws concerning the issuance of the Closing Shares.

       

      The Underlying Shares have been duly and validly authorized and reserved by the Company (to the extent required to be converted under
        the terms hereof) and, when issued upon conversion in accordance with this Agreement and the Certificate of Designation, will be validly issued, fully paid and non-assessable, and the issuance of such shares of Common Stock shall not be subject to
        any preemptive or similar rights.

       

      (p)          Capitalization.  The Company’s capitalization as disclosed in its filings with the Commission is true and complete, in all material respects, as of the date of such filings.

       

      (q)          Compliance with Securities Laws.  The Company is a reporting issuer in the United States, and is not in default under applicable U.S. federal securities laws, and is in
          compliance with its timely disclosure obligations under such laws and the requirements of each Trading Market on which the Common Stock is currently listed. No order, ruling or determination having the effect of suspending the sale or ceasing the
          trading of any securities of the Company has been issued or made by the Commission, any other securities commission, stock exchange or other regulatory authority and no proceedings for that purpose have been instituted or are pending or, to the
          Company’s Knowledge, are contemplated by any such authority. The Company is in material compliance with all applicable requirements of each applicable Trading Market. None of the applicable U.S. securities regulatory authorities or similar
          regulatory authority, any applicable Trading Market or any other competent authority has issued any order to cease or suspend trading of any securities of the Company, and the Company has not taken any action that is reasonably likely to result
          in the delisting of any securities of the Company that are listed or designated on any Trading Market.

       

      (r)          Operations in the Ordinary Course.  Except as set forth in or contemplated by the Company’s filings with the Commission since September 30, 2021, since September 30, 2021 the
          Company and its Subsidiaries have conducted their respective businesses in the ordinary course, consistent with past practice in all material respects, and there has been no (i) acquisition or disposition of any material asset by the Company or
          any of its Subsidiaries or any contract or arrangement therefor, other than acquisitions or dispositions for fair value in the ordinary course of business or acquisitions or dispositions as disclosed in the Company’s filings with the Commission
          or (ii) material change in the Company’s accounting principles, practices or methods.

       

      (s)          Insurance. The Company and its Subsidiaries are insured by insurers of recognized financial
            responsibility against such losses and risks and in such amounts as are prudent and customary in the businesses in which they are engaged. The Company does not have any reason to believe that it or any Subsidiary will not be able to renew its
            existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business in all material respects.

       

      
        -10-

        
          

      

      (t)          No Integrated Offering.  Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2, neither the Company, nor any of its Affiliates, nor
          any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this offering of the Securities to be integrated with
          prior offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any
          of the securities of the Company are listed or designated.

       

      (u)          Listing Rules.  The Company is not required to obtain any consent or approval from its stockholders in connection with the consummation of the transactions contemplated by this
          Agreement or any of the Transaction Documents pursuant to the rules of any Trading Market on which any of the securities of the Company are listed or designated.

       

       3.2.          Representations and Warranties of the Purchasers.  Each Purchaser, for itself and for no other Purchaser, hereby represents and warrants as of the date hereof
          and as of the Closing Date to the Company as follows (unless as of a specific date therein, in which case they shall be accurate as of such date):

       

      (a)          Organization; Authority.  Such Purchaser is either an individual or an entity duly incorporated or formed, validly existing and in good standing under the laws of the
          jurisdiction of its incorporation or formation with full right, corporate, partnership, limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the Transaction Documents and
          otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction Documents and performance by such Purchaser of the transactions contemplated by the Transaction Documents have been duly authorized by
          all necessary corporate, partnership, limited liability company or similar action, as applicable, on the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such
          Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance with its terms, except: (i) as limited by general equitable principles and applicable
          bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or
          other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law.

       

      (b)          Own Account.  Such Purchaser understands that the Securities are “restricted securities” and have not been registered under the Securities Act or any applicable state securities
          law and is acquiring the Securities as principal for its own account and not with a view to or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities law, has no
          present intention of distributing any of such Securities in violation of the Securities Act or any applicable state securities law and has no direct or indirect arrangement or understandings with any other persons to distribute or regarding the
          distribution of such Securities in violation of the Securities Act or any applicable state securities law (this representation and warranty not limiting such Purchaser’s right to sell the Securities pursuant to the Registration Statement or
          otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business.

       

      (c)          Purchaser Status.  At the time such Purchaser was offered the Closing Shares, it was, and as of the date hereof it is, and on each date on which it converts any Nonvoting
          Convertible Preferred Stock, it will be either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a “qualified institutional buyer” as defined in Rule 144A(a) under the
          Securities Act.

       

      (d)          Experience of Such Purchaser.  Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial
          matters so as to be capable of evaluating the merits and risks of the prospective investment in the Securities, and has so evaluated the merits and risks of such investment. Such Purchaser is able to bear the economic risk of an investment in the
          Securities and, at the present time, is able to afford a complete loss of such investment. Such Purchaser and its advisors, if any, have been furnished with all materials relating to the business, financial condition and results of operations of
          the Company, and materials relating to the offer and sale of the Securities, that have been requested by such Purchaser or its advisors, if any. Such Purchaser acknowledges and understands that its investment in the Securities involves a
          significant degree of risk.

       

      
        -11-

        
          

      

      (e)          General Solicitation.  Such Purchaser is not purchasing the Securities as a result of any advertisement, article, notice or other communication regarding the Securities
          published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or, to such Purchaser’s knowledge, any other general solicitation or general advertisement.

       

      (f)          Access to Information.  Such Purchaser acknowledges that it has had the opportunity to review the Transaction Documents (including all exhibits and schedules thereto) and the
          Exchange Act Reports and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the offering of the Securities
          and the merits and risks of investing in the Securities; (ii) access to information about the Company and its financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate its
          investment; and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the investment.

       

      (g)          Certain Transactions and Confidentiality.  Other than consummating the transactions contemplated hereunder, such Purchaser has not directly or indirectly, nor has any Person
          acting on behalf of or pursuant to any understanding with such Purchaser, executed any purchases or sales, including Short Sales, of the securities of the Company during the period commencing as of the time that such Purchaser first received a
          term sheet (written or oral) from the Company or any other Person representing the Company setting forth the material terms of the transactions contemplated hereunder and ending immediately prior to the execution hereof. Notwithstanding the
          foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment
          decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment
          decision to purchase the Securities covered by this Agreement. Other than to other Persons party to this Agreement or to such Purchaser’s representatives (including, without limitation, its officers, directors, partners, legal and other advisors,
          employees, agents and Affiliates), bound by a duty of confidentiality to such Purchaser and whom such Purchaser has taken reasonable actions to cause them to maintain such confidentiality, such Purchaser has maintained the confidentiality of all
          disclosures made to it in connection with this transaction (including the existence and terms of this transaction). Notwithstanding the foregoing, for the avoidance of doubt, nothing contained herein shall constitute a representation or warranty,
          or preclude any actions, with respect to the identification of the availability of, or securing of, available shares to borrow in order to effect Short Sales or similar transactions in the future.

       

      (h)          No Governmental Review.  Such Purchaser understands that no United States federal or state agency or any other government or governmental agency has passed on or made any
          recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the offering of the Securities.

       

      (i)          No Conflicts.  The execution, delivery and performance by such Purchaser of this Agreement and the consummation by such Purchaser of the transactions contemplated hereby will
          not (i) result in a violation of the organizational documents of such Purchaser or (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of
          termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which such Purchaser is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and
          state securities laws) applicable to such Purchaser, except in the case of clauses (ii) and (iii) above, for such that are not material and do not otherwise affect the ability of such Purchaser to consummate the transactions contemplated hereby.

       

      (j)          No Legal, Tax or Investment Advice.  Such Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser
          in connection with the purchase of the Securities constitutes legal, tax or investment advice. Such Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection
          with its purchase of the Securities.

       

      
        -12-

        
          

      

      The Company acknowledges and agrees that the representations contained in this Section 3.2 shall not modify, amend or affect such
        Purchaser’s right to rely on the Company’s representations and warranties contained in this Agreement or any representations and warranties contained in any other Transaction Document or any other document or instrument executed and/or delivered in
        connection with this Agreement or the consummation of the transactions contemplated hereby.

       

      ARTICLE IV.

        OTHER AGREEMENTS OF THE PARTIES

       

       4.1.          Transfer Restrictions.

       

      (a)          The Securities may only
          be disposed of in compliance with state and federal securities laws. In connection with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate of a Purchaser or in
          connection with a pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance
          of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities Act. As a condition of transfer, any such transferee shall agree
          in writing to be bound by the terms of this Agreement and the Registration Rights Agreement and shall have the rights and obligations of a Purchaser under this Agreement and the Registration Rights Agreement.

       

      (b)          The Purchasers agree to
          the imprinting, so long as is required by this Section 4.1, of a legend on any of the Securities in the following form:

       

      “THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE
        SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE TRANSFERRED UNLESS (I) SUCH SECURITIES HAVE BEEN REGISTERED FOR SALE PURSUANT TO THE
        SECURITIES ACT OF 1933, AS AMENDED, (II) SUCH SECURITIES MAY BE SOLD PURSUANT TO RULE 144, OR (III) THE COMPANY HAS RECEIVED AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSFER MAY LAWFULLY BE MADE WITHOUT REGISTRATION UNDER THE
        SECURITIES ACT OF 1933, AS AMENDED.”

       

      The Company acknowledges and agrees that a Purchaser may from time to time pledge pursuant to a bona fide margin agreement with a
        registered broker-dealer or grant a security interest in some or all of the Securities to a financial institution that is an “accredited investor” as defined in Rule 501(a) under the Securities Act and, if required under the terms of such
        arrangement, such Purchaser may transfer pledged or secured Securities to the pledgees or secured parties. Such a pledge or transfer would not be subject to approval of the Company and no legal opinion of legal counsel of the pledgee, secured party
        or pledgor shall be required in connection therewith. Further, no notice shall be required of such pledge. At the appropriate Purchaser’s expense, the Company will execute and deliver such reasonable documentation as a pledgee or secured party of
        Securities may reasonably request in connection with a pledge or transfer of the Securities, including, if the Securities are subject to registration pursuant to the Registration Rights Agreement, the preparation and filing of any required
        prospectus supplement under Rule 424(b)(3) under the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of Selling Securityholders (as defined in the Registration Rights Agreement) thereunder.

       

      
        -13-

        
          

      

      (c)          Instruments, whether
          certificated or uncertificated, evidencing the Securities shall not contain any legend (including the legend set forth in Section 4.1(b) hereof), (i) while a registration statement (including the Registration Statement) covering the resale of
          such security is effective under the Securities Act, (ii) following any sale of such Securities pursuant to Rule 144, (iii) if such Securities are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with
          the current public information required under Rule 144 as to such Securities and without volume or manner-of-sale restrictions, or (iv) if such legend is not required under applicable requirements of the Securities Act (including judicial
          interpretations and pronouncements issued by the staff of the Commission). Promptly after the Effective Date, the Company shall cause its counsel to issue a legal opinion to the Transfer Agent if required by the Transfer Agent to effect the
          removal of the legend hereunder. If all or any Nonvoting Convertible Preferred Stock is converted at a time when there is an effective registration statement to cover the resale of the Securities, or if such Securities may be sold under Rule 144
          and the Company is then in compliance with the current public information required under Rule 144, or if the Securities may be sold under Rule 144 without the requirement for the Company to be in compliance with the current public information
          required under Rule 144 as to such Securities or if such legend is not otherwise required under applicable requirements of the Securities Act (including judicial interpretations and pronouncements issued by the staff of the Commission) then such
          Securities shall be issued free of all legends. The Company agrees that following the Effective Date or at such time as such legend is no longer required under this Section 4.1(c), it will, as soon as practicable and no later than five Trading
          Days following the delivery by a Purchaser to the Company or the Transfer Agent of a certificate or book entry (at the election of such Purchaser, provided absent instructions to the contrary the default shall be book-entry) representing
          Securities, as the case may be, issued with a restrictive legend, deliver or cause to be delivered to such Purchaser an unrestricted book entry representing such shares that is free from all restrictive and other legends. The Company may not make
          any notation on its records or give instructions to the Transfer Agent that enlarge the restrictions on transfer set forth in this Section 4. Instruments, whether certificated or uncertificated, for Securities subject to legend removal hereunder
          shall be transmitted by the Transfer Agent to the Purchaser by crediting the account of the Purchaser’s prime broker with the Depository Trust Company System as directed by such Purchaser.

       

       4.2.          Lock-up.  Notwithstanding any provision of this Agreement to the contrary, each Purchaser hereby agrees that, without the prior written consent of the Company,
          such Purchaser will not (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or
          indirectly, any shares of Common Stock or any securities (for the avoidance of doubt, including Nonvoting Convertible Preferred Stock) convertible into or exercisable or exchangeable for Common Stock (including without limitation, Common Stock or
          such other securities which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the Securities and Exchange Commission and securities which may be issued upon exercise of a stock option or
          warrant), or publicly disclose the intention to make any such offer, sale, pledge or disposition, or (2) enter into any swap or other agreement that transfers, in whole or in part, any of the economic consequences of ownership of the Common Stock
          or such other securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of Common Stock or such other securities, in cash or other-wise until March 15, 2022 (the “Lock-Up Period”).  The Company will direct its transfer agent to place stop transfer restrictions upon any such securities of the Company that are bound by the restrictions set forth
          in this Section 4.2 for the duration of the Lock-Up Period.1  For the avoidance of doubt, nothing in this Section 4.2 shall prohibit the purchase of shares of Common Stock in the open market or otherwise.

       

       4.3.          Furnishing of Information; Public Information.  Until no Purchaser owns Securities, the Company covenants to use commercially reasonable efforts to maintain
          the registration of the Common Stock under Section 12(b) or 12(g) of the Exchange Act and to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after
          the date hereof pursuant to the Exchange Act even if the Company is not then subject to the reporting requirements of the Exchange Act.

       

       4.4.          Integration.  The Company shall not sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of
          the Securities Act) that would be integrated with the offer or sale of the Securities in a manner that would require the registration under the Securities Act of the sale of the Securities or that would be integrated with the offer or sale of the
          Securities for purposes of the rules and regulations of any Trading Market such that it would require shareholder approval prior to the closing of such other transaction unless shareholder approval is obtained before the closing of such
          subsequent transaction.

       

      

      1 Date that is 90 days after Closing.

       

      
        -14-

        
          

      

       4.5.          Securities Laws Disclosure; Publicity.  The Company shall (a) by 9:30 a.m. (New York City time) on the Trading Day immediately following the date hereof, issue
          a press release disclosing the material terms of the transactions contemplated hereby, and (b) file a Current Report on Form 8-K, including the Transaction Documents as exhibits thereto, with the Commission within the time required by the
          Exchange Act. From and after the issuance of such press release, the Company represents to the Purchasers that it shall have publicly disclosed all material, non-public information delivered to any of the Purchasers by the Company, or any of its
          officers, directors, employees or agents. The Company and each Purchaser shall consult with each other in issuing any other press releases with respect to the transactions contemplated hereby, and neither the Company nor any Purchaser shall issue
          any such press release nor otherwise make any such public statement without the prior consent of the Company, with respect to any press release of any Purchaser, or without the prior consent of each Purchaser, with respect to any press release of
          the Company, which consent shall not unreasonably be withheld or delayed, except if such disclosure is required by law, in which case the disclosing party shall promptly provide the other party with prior notice of such public statement or
          communication.

       

       4.6.          Shareholder Rights Plan.  No claim will be made or enforced by the Company or, with the consent of the Company, any other Person, that any Purchaser is an “Acquiring Person” under any control share acquisition, business combination, poison pill (including any distribution under a rights agreement) or similar
          anti-takeover plan or arrangement in effect or hereafter adopted by the Company, or that any Purchaser could be deemed to trigger the provisions of any such plan or arrangement, by virtue of receiving Securities under the Transaction Documents or
          under any other agreement between the Company and the Purchasers.

       

       4.7.          Non-Public Information.  Except with respect to the material terms and conditions of the transactions contemplated by the Transaction Documents, which shall be
          disclosed pursuant to Section 4.5, the Company covenants and agrees that neither it, nor any other Person acting on its behalf will provide any Purchaser or its agents or counsel with any information that constitutes, or the Company reasonably
          believes constitutes, material non-public information, unless prior thereto such Purchaser shall have consented to the receipt of such information and agreed with the Company to keep such information confidential. The Company understands and
          confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. To the extent that the Company delivers any material, non-public information to a Purchaser without such Purchaser’s
          consent, the Company hereby covenants and agrees that such purchaser shall not have any duty of confidentiality to Company, any of its Subsidiaries, or any of their respective officers, directors, agents, employees or Affiliates, or a duty to the
          Company, and of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates not to trade on the basis of, such material, non-public information, provided that the Purchaser shall remain subject to applicable
          law. To the extent that any notice provided pursuant to any Transaction Document constitutes, or contains, material, non-public information regarding the Company or any Subsidiaries, the Company shall simultaneously file such notice with the
          Commission pursuant to a Current Report on Form 8-K. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company.

       

       4.8.          Use of Proceeds.  The Company shall use the net proceeds from the sale of the Securities hereunder for working capital purposes and shall not use such
          proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than payment of trade payables in the ordinary course of the Company’s business and prior practices), (b) for the redemption of any Common Stock or Common Stock
          Equivalents, (c) for the settlement of any outstanding litigation or (d) in violation of FCPA or OFAC regulations.

       

      
        -15-

        
          

      

       4.9.          Indemnification of Purchasers.  Subject to the provisions of this Section 4.9, the Company will indemnify and hold each Purchaser and its directors, officers,
          shareholders, members, partners, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each Person who controls such Purchaser
          (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a functionally equivalent role of a Person
          holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”) harmless from any and
          all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party
          may suffer or incur as a result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against
          the Purchaser Parties in any capacity, or any of them or their respective Affiliates, by any stockholder of the Company who is not an Affiliate of such Purchaser Parties, with respect to any of the transactions contemplated by the Transaction
          Documents (unless such action is based upon a breach of such Purchaser Party’s representations, warranties or covenants under the Transaction Documents or any agreements or understandings such Purchaser Parties may have with any such stockholder
          or any violations by such Purchaser Parties of state or federal securities laws or any conduct by such Purchaser Parties which constitutes fraud, gross negligence, willful misconduct or malfeasance). If any action shall be brought against any
          Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and the Company shall have the right to assume the defense thereof with counsel of its own
          choosing reasonably acceptable to the Purchaser Party. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses of such counsel shall be at the
          expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time to assume such defense and to employ
          counsel or (iii) in such action there is, in the reasonable opinion of counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser Party, in which case the Company shall be responsible
          for the reasonable fees and expenses of no more than one such separate counsel. The Company will not be liable to any Purchaser Party under this Agreement (y) for any settlement by a Purchaser Party effected without the Company’s prior written
          consent, which shall not be unreasonably withheld or delayed; or (z) to the extent, but only to the extent that a loss, claim, damage or liability is attributable to (A) any Purchaser Party’s breach of any of the representations, warranties,
          covenants or agreements made by such Purchaser Party in this Agreement or in the other Transaction Documents, or (B) any conduct by such Purchaser Party which constitutes gross negligence or willful misconduct. The indemnification required by
          this Section 4.9 shall be made by periodic payments of the amount thereof during the course of the investigation or defense, as and when bills are received or are incurred. The indemnity agreements contained herein shall be in addition to any
          cause of action or similar right of any Purchaser Party against the Company or others and any liabilities the Company may be subject to pursuant to law.

       

       4.10.          Reservation and Listing of Securities.  The Company shall maintain and keep available at all times, free of preemptive rights, a reserve of the Required
          Minimum from its duly authorized shares of Common Stock for issuance pursuant to the Transaction Documents in such amount as may then be required to fulfill its obligations in full under the Transaction Documents.

       

       4.11.          Listing of Common Stock.  The Company hereby agrees to use commercially reasonable efforts to maintain the listing or quotation of the Common Stock on the
          Trading Market on which it is currently listed, and concurrently with the Closing, the Company shall apply to list or quote all of the Common Stock and Underlying Shares on such Trading Market and promptly secure the listing of all of the Common
          Stock and Underlying Shares on such Trading Market. The Company further agrees, if the Company applies to have the Common Stock traded on any other Trading Market, it will then include in such application all of the Underlying Shares, and will
          take such other action as is necessary to cause all of the Underlying Shares to be listed or quoted on such other Trading Market as promptly as possible. The Company will then take all commercially reasonable action necessary to continue the
          listing or quotation and trading of its Common Stock on a Trading Market and will comply in all respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Trading Market. The Company agrees to maintain
          the eligibility of the Common Stock for electronic transfer through the Depository Trust Company or another established clearing corporation, including, without limitation, by timely payment of fees to the Depository Trust Company or such other
          established clearing corporation in connection with such electronic transfer.

       

       4.12.          Conversion Procedures.  The form of Notice of Conversion included in the Certificate of Designation sets forth the totality of the procedures required of the
          Purchasers in order to convert the Nonvoting Convertible Preferred Stock. Without limiting the preceding sentences, no ink-original Notice of Conversion shall be required, nor shall any medallion guarantee (or other type of guarantee or
          notarization) of any Notice of Conversion form be required in order to convert the Nonvoting Convertible Preferred Stock, unless required by the Transfer Agent. No additional legal opinion, other information or instructions shall be required of
          the Purchasers to convert their Nonvoting Convertible Preferred Stock. The Company shall honor conversions of the Nonvoting Convertible Preferred Stock and shall deliver Underlying Shares in accordance with the terms, conditions and time periods
          set forth in the Transaction Documents.

       

      
        -16-

        
          

      

       4.13.          Certain Transactions and Confidentiality.  Each Purchaser, severally and not jointly with the other Purchasers, covenants that neither it, nor any Affiliate
          acting on its behalf or pursuant to any understanding with it will execute any purchases or sales, including Short Sales, of any of the Company’s securities during the period commencing with the execution of this Agreement and ending at such time
          that the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.5. Each Purchaser, severally and not jointly with the other Purchasers, covenants that until such
          time as the transactions contemplated by this Agreement are publicly disclosed by the Company pursuant to the initial press release as described in Section 4.6, such Purchaser will maintain the confidentiality of the existence and terms of this
          transaction and the information included in the Transaction Documents. Notwithstanding the foregoing, and notwithstanding anything contained in this Agreement to the contrary, the Company expressly acknowledges and agrees that (i) no Purchaser
          makes any representation, warranty or covenant hereby that it will not engage in effecting transactions in any securities of the Company after the time that the transactions contemplated by this Agreement are first publicly announced pursuant to
          the initial press release as described in Section 4.5, (ii) no Purchaser shall be restricted or prohibited from effecting any transactions in any securities of the Company in accordance with applicable securities laws from and after the time that
          the transactions contemplated by this Agreement are first publicly announced pursuant to the initial press release as described in Section 4.5 and (iii) no Purchaser shall have any duty of confidentiality or duty not to trade in the securities of
          the Company to the Company after the issuance of the initial press release as described in Section 4.5. Notwithstanding the foregoing, in the case of a Purchaser that is a multi-managed investment vehicle whereby separate portfolio managers
          manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Purchaser’s assets, the covenant set forth above
          shall only apply with respect to the portion of assets managed by the portfolio manager that made the investment decision to purchase the Securities covered by this Agreement.

       

       4.14.          Form D; Blue Sky Filings.  The Company agrees to timely file a Form D with respect to the Securities as required under Regulation D and to provide a copy
          thereof, promptly upon request of any Purchaser. The Company shall take such action as the Company shall reasonably determine is necessary in order to obtain an exemption for, or to qualify the Securities for, sale to the Purchasers at the
          Closing under applicable securities or “Blue Sky” laws of the states of the United States, and shall provide evidence of such actions promptly upon request of any Purchaser.

       

      ARTICLE V.

        MISCELLANEOUS

       

       5.1.          Termination.  This Agreement may be terminated by any Purchaser, as to such Purchaser’s obligations hereunder only and without any effect whatsoever on the
          obligations between the Company and the other Purchasers, by written notice to the other parties, if the Closing has not been consummated on or before December 15, 2021; provided, however, that the right to terminate this Agreement under this Section 5.1 shall not be available to a Purchaser whose
          failure to fulfill any obligation under this Agreement has been the proximate cause of or resulted in the failure of the transactions contemplated hereunder to occur on or before such date; provided further, however,
          that such termination will not affect the right of any party to sue for any breach by any other party (or parties).

       

       5.2.          Fees and Expenses.  At the Closing, the Company shall pay the reasonable and documented fees and expenses of Willkie Farr & Gallagher LLP, the counsel for
          Masters Special Situations, LLC, in an amount not to exceed, in the aggregate, $150,000.  The Company shall pay all Transfer Agent fees (including, without limitation, any fees required for same-day processing of any instruction letter delivered
          by the Company and any Notice of Conversion delivered by a Purchaser), stamp taxes and other similar taxes and duties levied in connection with the delivery of any Securities to the Purchasers.  Except as set forth above, each party shall pay its
          own fees and expenses in connection with the transactions contemplated by the Transaction Documents.

       

       5.3.          Entire Agreement.  The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the parties with respect to
          the subject matter hereof and thereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

       

      
        -17-

        
          

      

       5.4.          Notices.  Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed
          given and effective on the earliest of: (a) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment as set forth on the signature pages attached hereto at or prior to 5:30
          p.m. (New York City time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number or email attachment as set forth on the signature pages
          attached hereto on a day that is not a Trading Day or later than 5:30 p.m. (New York City time) on any Trading Day, (c) the second (2nd) Trading Day following the
          date of mailing, if sent by U.S. nationally recognized overnight courier service or (d) upon actual receipt by the party to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the
          signature pages attached hereto, with, in the case of the Purchasers, a copy to:  Willkie Farr & Gallagher LLP, 787 Seventh Avenue, New York, New York 10019, Attn: Matthew J. Rizzo (mrizzo@willkie.com) and Sean M. Ewen (sewen@willkie.com).

       

       5.5.          Amendments; Waivers.  No provision of this Agreement may be waived, modified, supplemented or amended except in a written instrument signed, in the case of an
          amendment, by the Company and the Purchasers holding a majority of the Securities then outstanding or, in the case of a waiver, by the party against whom enforcement of any such waived provision is sought, provided that if any amendment,
          modification or waiver disproportionately and adversely impacts a Purchaser (or group of Purchasers), the consent of such disproportionately impacted Purchaser (or group of Purchasers) shall also be required. No waiver of any default with respect
          to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or
          omission of any party to exercise any right hereunder in any manner impair the exercise of any such right. Any proposed amendment or waiver that disproportionately, materially and adversely affects the rights and obligations of any Purchaser
          relative to the comparable rights and obligations of the other Purchasers shall require the prior written consent of such adversely affected Purchaser, Any amendment effected in accordance with this Section 5.5 shall be binding upon each
          Purchaser and holder of Securities and the Company.

       

       5.6.          Headings.  The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the
          provisions hereof.

       

       5.7.          Successors and Assigns.  This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company
          may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser (other than by merger). Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such
          Purchaser assigns or transfers any Securities, provided that such transferee agrees in writing to be bound, with respect to the transferred Securities, by the provisions of the Transaction Documents that apply to the “Purchasers.”

       

       5.8.          No Third-Party Beneficiaries.  This Agreement is intended for the benefit of the parties hereto and their respective successors and permitted assigns and is
          not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Section 4.9.

       

       5.9.          Governing Law.  All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be governed by and
          construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all legal Proceedings concerning the interpretations, enforcement and
          defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective affiliates, directors, officers, shareholders, partners, members, employees or agents) shall
          be commenced exclusively in the state and federal courts sitting in the City of New York. Each party hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in the City of New York, Borough of Manhattan
          for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably
          waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such Proceeding is improper or is an inconvenient venue for such Proceeding. Each party hereby irrevocably
          waives personal service of process and consents to process being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for
          notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other
          manner permitted by law. If any party hereto shall commence a Proceeding to enforce any provisions of the Transaction Documents, then, in addition to the obligations of the Company under Section 4.9, the prevailing party in such Proceeding shall
          be reimbursed by the non-prevailing party for its reasonable attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

       

      
        -18-

        
          

      

       5.10.          Survival.  The representations and warranties contained herein shall survive the Closing and the delivery of the Securities.

       

       5.11.          Execution.  This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and
          shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile
          transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile
          or “.pdf” signature page were an original thereof.

       

       5.12.          Severability.  If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be invalid, illegal, void or
          unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their commercially
          reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be the intention of the
          parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable.

       

       5.13.          Rescission and Withdrawal Right.  Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) any of the other
          Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligations within the periods therein provided, then such Purchaser may
          rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in whole or in part without prejudice to its future actions and rights; provided, however, that in the case of a rescission of a conversion of the Nonvoting
          Convertible Preferred Stock, the applicable Purchaser shall be required to return any Underlying Shares subject to any such rescinded Notice of Conversion concurrently therewith.

       

       5.14.          Replacement of Securities.  If any certificate or instrument evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or
          cause to be issued in exchange and substitution for and upon cancellation thereof (in the case of mutilation), or in lieu of and substitution therefor, a new certificate or instrument, but only upon receipt of evidence reasonably satisfactory to
          the Company of such loss, theft or destruction. The applicant for a new certificate or instrument under such circumstances shall also pay any reasonable third-party costs (including customary indemnity) associated with the issuance of such
          replacement Securities.

       

       5.15.          Remedies.  In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and
          the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations contained in the
          Transaction Documents and hereby agree to waive and not to assert in any Action for specific performance of any such obligation the defense that a remedy at law would be adequate.

       

       5.16.          Payment Set Aside.  To the extent that the Company makes a payment or payments to any Purchaser pursuant to any Transaction Document or a Purchaser enforces or
          exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside, recovered from, disgorged by or
          are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of action),
          then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not
          occurred.

       

      
        -19-

        
          

      

       5.17.          Usury.  To the extent it may lawfully do so, the Company hereby agrees not to insist upon or plead or in any manner whatsoever claim, and will resist any and
          all efforts to be compelled to take the benefit or advantage of, usury laws wherever enacted, now or at any time hereafter in force, in connection with any Proceeding that may be brought by any Purchaser in order to enforce any right or remedy
          under any Transaction Document. Notwithstanding any provision to the contrary contained in any Transaction Document, it is expressly agreed and provided that the total liability of the Company under the Transaction Documents for payments in the
          nature of interest shall not exceed the maximum lawful rate authorized under applicable law (the “Maximum Rate”), and, without limiting the foregoing, in
          no event shall any rate of interest or default interest, or both of them, when aggregated with any other sums in the nature of interest that the Company may be obligated to pay under the Transaction Documents exceed such Maximum Rate. It is
          agreed that if the maximum contract rate of interest allowed by law and applicable to the Transaction Documents is increased or decreased by statute or any official governmental action subsequent to the date hereof, the new maximum contract rate
          of interest allowed by law will be the Maximum Rate applicable to the Transaction Documents from the effective date thereof forward, unless such application is precluded by applicable law. If under any circumstances whatsoever, interest in excess
          of the Maximum Rate is paid by the Company to any Purchaser with respect to indebtedness evidenced by the Transaction Documents, such excess shall be applied by such Purchaser to the unpaid principal balance of any such indebtedness or be
          refunded to the Company, the manner of handling such excess to be at such Purchaser’s election.

       

       5.18.          Independent Nature of Purchasers’ Obligations and Rights.  The obligations of each Purchaser under any Transaction Document are several and not joint with the
          obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance or non-performance of the obligations of any other Purchaser under any Transaction Document. Nothing contained herein or in any other
          Transaction Document, and no action taken by any Purchaser pursuant hereof or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the
          Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including,
          without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such purpose. Each Purchaser
          has been represented by its own separate legal counsel in its review and negotiation of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and Transaction Documents for the convenience of the Company
          and not because it was required or requested to do so by any of the Purchasers. It is expressly understood and agreed that each provision contained in this Agreement and in each other Transaction Document is between the Company and a Purchaser,
          solely, and not between the Company and the Purchasers collectively and not between and among the Purchasers.

       

       5.19.          Liquidated Damages.  The Company’s obligations to pay any partial liquidated damages or other amounts owing under the Transaction Documents is a continuing
          obligation of the Company and shall not terminate until all unpaid partial liquidated damages and other amounts have been paid notwithstanding the fact that the instrument or security pursuant to which such partial liquidated damages or other
          amounts are due and payable shall have been canceled.

       

       5.20.          Saturdays, Sundays, Holidays, etc.  If the last or appointed day for the taking of any action or the expiration of any right required or granted herein shall
          not be a Business Day, then such action may be taken or such right may be exercised on the next succeeding Business Day.

       

       5.21.          Construction.  The parties agree that each of them and/or their respective counsel have reviewed and had an opportunity to revise the Transaction Documents
          and, therefore, the normal rule of construction to the effect that any ambiguities are to be resolved against the drafting party shall not be employed in the interpretation of the Transaction Documents or any amendments thereto. In addition, each
          and every reference to share prices and shares of Common Stock in any Transaction Document shall be subject to adjustment for reverse and forward stock splits, stock dividends, stock combinations and other similar transactions of the Common Stock
          that occur after the date of this Agreement.

       

       5.22.          WAIVER

            OF JURY TRIAL. IN ANY ACTION, SUIT, OR PROCEEDING IN ANY JURISDICTION BROUGHT BY ANY PARTY AGAINST ANY OTHER PARTY, THE PARTIES EACH KNOWINGLY AND INTENTIONALLY, TO THE GREATEST EXTENT PERMITTED BY APPLICABLE LAW, HEREBY ABSOLUTELY,
            UNCONDITIONALLY, IRREVOCABLY AND EXPRESSLY WAIVES FOREVER TRIAL BY JURY.

       

      (Signature Pages Follow)

       

      
        -20-

        
          

      

      IN WITNESS WHEREOF, the parties hereto have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              VENUS CONCEPT INC.

            	
              Address for Notice:

            
	 	 
	
              By:

            	
              /s/ Domenic Serafino

            	 	
              Venus Concept Inc.

              235 Yorkland Blvd., Suite 900

            
	 	
              Name: Domenic Serafino

            	
              Toronto, Ontario, Canada

            
	 	
              Title: CEO

              

            	
              M2J 4Y8

            
	 	
              Attn: General Counsel and Corporate Secretary

                Email:  mmandarello@venusconcept.com

            
	 	
              With a copy to (which shall not constitute notice):

            
	 	
              Dorsey & Whitney LLP

            
	 	
              TD Canada Trust Tower

            
	 	
              Brookfield Place 161 Bay Street, Suite 4310

            
	 	
              Toronto, ON M5J 2S1

            
	 	
              Attn:  Richard Raymer

            
	 	
              Email:  raymer.richard@dorsey.com

            

       

      

      [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK

       

      SIGNATURE PAGES FOR PURCHASERS FOLLOWS]

       

      
        -21-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              Marlin Fund, Limited Partnership

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Michael W. Masters

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Michael W. Masters

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Managing Member of the General Partner

            	 
	 	 	 

      Address for Notice:

       

      3060 Peachtree Road, NW, Ste 1425 Atlanta, GA 30305

       

      Subscription Amount: $2,201,500

       

      Shares of Common Stock: 1,761,200

      

       

      Shares of Nonvoting Convertible Preferred Stock: 0

        

       

      
        -22-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              Marlin Fund II, Limited Partnership

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Michael W. Masters

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Michael W. Masters

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Managing Member of the General Partner

            	 
	 	 	 

      Address for Notice:

       

      3060 Peachtree Road, NW, Ste 1425 Atlanta, GA 30305

       

      Subscription Amount: $1,640,500

       

      Shares of Common Stock: 1,312,400

      

       

      Shares of Nonvoting Convertible Preferred Stock: 0

        

       

      
        -23-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              Marlin Fund III, Limited Partnership

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Michael W. Masters

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Michael W. Masters

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Managing Member of the General Partner

            	 
	 	 	 

      Address for Notice:

       

      3060 Peachtree Road, NW, Ste 1425 Atlanta, GA 30305

       

      Subscription Amount: $148,750

       

      Shares of Common Stock: 119,000

      

       

      Shares of Nonvoting Convertible Preferred Stock: 0

        

       

      
        -24-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              Marlin Master Fund Offshore II, LP

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Michael W. Masters

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Michael W. Masters

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Managing Member of the General Partner

            	 
	 	 	 

      Address for Notice:

       

      3060 Peachtree Road, NW, Ste 1425 Atlanta, GA 30305

       

      Subscription Amount: $259,250

       

      Shares of Common Stock: 207,400

      

       

      Shares of Nonvoting Convertible Preferred Stock: 0

        

       

      
        -25-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT] 

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              MSS VC SPV LP

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Michael W. Masters

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Michael W. Masters

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Managing Member of the Managing Member of the General Partner

            	 
	 	 	 

      Address for Notice:

       

      3060 Peachtree Road, NW, Ste 1425 Atlanta, GA 30305

       

      Subscription Amount: $5,748,966.25

       

      Shares of Common Stock: 808,418

      

       

      Shares of Nonvoting Convertible Preferred Stock: 3,790,755

        

       

      
        -26-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              EW Healthcare Partners, L.P.

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Scott Barry

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Scott Barry

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Its Authorized Signatory

            	 
	 	 	 

      Address for Notice:

       

      21 WaterWay Ave, Suite 225, The Woodlands, TX 77380

       

      Subscription Amount: $4,710,485

       

      Shares of Common Stock: 3,768,388

      

       

      Shares of Nonvoting Convertible Preferred Stock:  0

       

      
        -27-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              EW Healthcare Partners-A, L.P.

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Scott Barry

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Scott Barry

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Its Authorized Signatory

            	 
	 	 	 

      Address for Notice:

       

      21 WaterWay Ave, Suite 225, The Woodlands, TX 77380

       

      Subscription Amount: $189,515

       

      Shares of Common Stock: 151,612

      

       

      Shares of Nonvoting Convertible Preferred Stock:  0

       

      
        -28-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              Healthquest Partners II, L.P.

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Garheng Kong

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Garheng Kong

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              Managing Partner

            	 
	 	 	 

      Address for Notice:

       

      1301 Shoreway Road, Suite 350, Belmont, CA 94002

       

      Subscription Amount: $2,000,000

       

      Shares of Common Stock: 1,600,000

      

       

      Shares of Nonvoting Convertible Preferred Stock:  0

       

      
        -29-

        
          

      

      [PURCHASER SIGNATURE PAGES TO VENUS CONCEPT INC. STOCK PURCHASE AGREEMENT]

       

      IN WITNESS WHEREOF, the undersigned have caused this Stock Purchase Agreement to be duly executed by their respective authorized
        signatories as of the date first indicated above.

       

      	
              Name of Purchaser:

            	
              Keith J Sullivan Trustee UAD 11/04/2016 Keith J Sullivan Revocable Trust

            
	 	 	 
	
              Signature of Authorized Signatory of Purchaser:

            	
              /s/ Keith Sullivan

            	 
	 	 	 
	
              Name of Authorized Signatory:

            	
              Keith Sullivan

            	 
	 	 	 
	
              Title of Authorized Signatory:

            	
              President & CEO

            	 
	 	 	 

      Address for Notice:

       

      8860 North Sea Oaks Way #109, Vero Beach, Florida 32963

       

      Subscription Amount: $100,000

       

      Shares of Common Stock: 80,000

      

       

      Shares of Nonvoting Convertible Preferred Stock:  0

       

      
        -30-

        
          

      

      EXHIBIT A

      CERTIFICATE OF DESIGNATION

       

      
        -31-

        
          

      

      EXHIBIT B

      REGISTRATION RIGHTS AGREEMENT

       

      
        -32-

        
          

      

      EXHIBIT C

      INVESTOR RIGHTS AGREEMENT

       

      
        -33-

        
          

      

      EXHIBIT D

      LEGAL OPINION OF COMPANY COUNSEL

       

      	

            	1.	
              The Company is a validly existing corporation and in good standing under the laws of the State of Delaware.

            

       

      	

            	2.	
              The execution and delivery of the Transaction Documents by the Company and the issuance and sale of the Securities pursuant to the Purchase Agreement do not (a)
                constitute a default under or a breach of any Reviewed Agreement, (b) violate any provision of the articles or bylaws of the Company, or (c) violate any U.S. Federal or New York statute, law, rule or regulation which, in our experience is
                typically applicable to transactions of the nature contemplated by the Transaction Documents, in each case of (a) and (c) to the extent the violation of which would materially and adversely affect the Company and its subsidiaries, taken as
                a whole.

            

       

      	

            	3.	
              All consents, approvals, authorizations, or orders of, and filings, registrations, and qualifications with any U.S. Federal regulatory authority or governmental body
                required for the issuance of the Securities has been made or obtained, other than filings required to be made under U.S. federal or “blue sky” laws, applicable Canadian securities laws and applicable stock exchange requirements that may be
                made properly after the issuance of the Securities.

            

       

      	

            	4.	
              The offer and sale of the Securities are exempt from the registration requirements of the Securities Act.

            

       

      	

            	5.	
              The execution and delivery of the Transaction Documents and the issuance of the Securities have been duly authorized by the Company, and the Transaction Documents
                have been duly executed and delivered by the Company.

            

       

      	

            	6.	
              The Company is not, and, after giving effect to the issue and sale of the Securities, will not be, required to be registered as an “investment company” under the 1940
                Act.

            

       

      	

            	7.	
              The Securities have been duly authorized and upon issuance and delivery against payment therefore in accordance with the terms of the Purchase Agreement, will be
                validly issued, fully paid and nonassessable.

            

       

      
        -34-

        
          

      

      SCHEDULE 3.1(C)

       

      Venus Concept (HK) Limited is owned 49% by minority investors.

       

       

      

    

      -35-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]